<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="review-article">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15938</article-id>
<article-id pub-id-type="publisher-id">OL-33-1-15938</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Progress in anticancer chemical constituents and pharmacological research of <italic>Carpesium cernuum </italic>L. (Review)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Mao</surname><given-names>Jingxin</given-names></name>
<xref rid="af1-ol-33-1-15938" ref-type="aff">1</xref>
<xref rid="af2-ol-33-1-15938" ref-type="aff">2</xref>
<xref rid="fn1-ol-33-1-15938" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name>
<xref rid="af1-ol-33-1-15938" ref-type="aff">1</xref>
<xref rid="fn1-ol-33-1-15938" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Mengqian</given-names></name>
<xref rid="af1-ol-33-1-15938" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Qing</given-names></name>
<xref rid="af2-ol-33-1-15938" ref-type="aff">2</xref>
<xref rid="c1-ol-33-1-15938" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Hongmei</given-names></name>
<xref rid="af3-ol-33-1-15938" ref-type="aff">3</xref>
<xref rid="af4-ol-33-1-15938" ref-type="aff">4</xref>
<xref rid="c2-ol-33-1-15938" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-ol-33-1-15938"><label>1</label>Technology Development Center, Chongqing Medical and Pharmaceutical College, Chongqing 401331, P.R. China</aff>
<aff id="af2-ol-33-1-15938"><label>2</label>Department of Science and Education, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing 400060, P.R. China</aff>
<aff id="af3-ol-33-1-15938"><label>3</label>Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China</aff>
<aff id="af4-ol-33-1-15938"><label>4</label>State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, Jiangsu 210009, P.R. China</aff>
<author-notes>
<corresp id="c1-ol-33-1-15938"><italic>Correspondence to</italic>: Professor Qing Hu, Department of Science and Education, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, 301 Nancheng Avenue, Nan&#x0027;an, Chongqing 400060, P.R. China, E-mail: <email>476368580@qq.com</email></corresp>
<corresp id="c2-ol-33-1-15938">Professor Hongmei Wang, Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong, Chongqing 400016, P.R. China, E-mail: <email>wanghongmei225@126.com</email></corresp>
<fn id="fn1-ol-33-1-15938"><label>&#x002A;</label><p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="collection"><month>01</month><year>2027</year></pub-date>
<pub-date pub-type="epub"><day>04</day><month>11</month><year>2026</year></pub-date>
<volume>33</volume>
<issue>1</issue>
<elocation-id>3</elocation-id>
<history>
<date date-type="received"><day>01</day><month>03</month><year>2026</year></date>
<date date-type="accepted"><day>22</day><month>09</month><year>2026</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Mao et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The present study aimed to systematically review the anticancer chemical constituents, pharmacological effects, and molecular targets of <italic>Carpesium cernuum</italic> L., clarify the molecular network of its anticancer mechanisms, summarize the research achievements and limitations and provide a scientific reference for its development and utilization, the research and development of novel anticancer drugs, and clinical applications. Through literature collation and experimental data integration, the chemical constituents of <italic>C. cernuum</italic> were classified and identified, and with the aid of <italic>in vitro</italic> cell experiments, partial <italic>in vivo</italic> animal experiments and molecular biology techniques, the anticancer effects of its extracts and active constituents as well as the key signaling pathways were investigated. Notably, all included evidence was strictly stratified by research type (crude extract/fraction/isolated monomer, <italic>in vitro</italic> cell model/<italic>in vivo</italic> animal model/network pharmacology prediction) to clarify the evidence level of each anticancer claim. A total of 109 compounds were isolated and identified from <italic>C. cernuum</italic>, among which 60 sesquiterpenoids were the major components. Its active constituents exhibited promising inhibitory effects in preclinical studies against multiple cancers including prostate cancer, pancreatic cancer, leukemia and breast cancer. Existing anticancer evidence was predominantly derived from <italic>in vitro</italic> cell-based assays, with a small number of <italic>in vivo</italic> animal validations and preliminary network pharmacology predictions; high-level clinical evidence is still vacant. By regulating signaling pathways such as phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR and Hippo, they exert multi-dimensional anticancer effects, including cell proliferation inhibition, apoptosis induction, and metastasis suppression. <italic>In vitro</italic> and partial <italic>in vivo</italic> preclinical evidence indicates that the active ingredients of <italic>C. cernuum</italic> exert potential inhibitory effects against various tumors such as prostate cancer and pancreatic cancer. By targeting key signaling pathways including PI3K/Akt/mTOR and Hippo, it achieves multi-modal anticancer effects such as proliferation inhibition and apoptosis induction, showing favorable preliminary biocompatibility in existing preclinical experiments. However, the current research has limitations including insufficient <italic>in vivo</italic> verification, uneven evidence quality, and lack of standardized dose-effect data, which restrict clinical transformation. Collectively, <italic>C. cernuum</italic> and its bio-active metabolites display pre-clinical antitumor potential, yet further pharmacological validation and translational investigations are required to evaluate clinical applicability</p>
</abstract>
<kwd-group>
<kwd><italic>Carpesium cernuum</italic> L.</kwd>
<kwd>anticancer</kwd>
<kwd>chemical constituent</kwd>
<kwd>pharmacological effect</kwd>
<kwd>signaling pathways</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Open Research Projects of the State Key Laboratory of Neurology and Oncology Drug Development</funding-source>
<award-id>SKLSIM-20251168</award-id>
</award-group>
<award-group>
<funding-source>2026 Chongqing Municipal Health Commission&#x0027;s Traditional Chinese Medicine Research Projects</funding-source>
<award-id>2026WSJK171</award-id>
</award-group>
<award-group>
<funding-source>Science and Technology Research Program of Chongqing Municipal Education Commission</funding-source>
<award-id>KJQN202502805</award-id>
<award-id>KJQN202602801</award-id>
<award-id>KJZD-M202502802</award-id>
</award-group>
<award-group>
<funding-source>2025 Innovation Group Project of Chongqing Medical and Pharmaceutical College</funding-source>
<award-id>YGZZK2025502</award-id>
</award-group>
<award-group>
<funding-source>Scientific Research Project of Chongqing Medical and Pharmaceutical College</funding-source>
<award-id>YGZRC2024104</award-id>
<award-id>YGZ2022104</award-id>
</award-group>
<award-group>
<funding-source>Technological Innovation Project of Shapingba District, Chongqing</funding-source>
<award-id>2025017</award-id>
</award-group>
<funding-statement>The present study was financially supported by the Open Research Projects of the State Key Laboratory of Neurology and Oncology Drug Development (grant no. SKLSIM-20251168), the 2026 Chongqing Municipal Health Commission&#x0027;s Traditional Chinese Medicine Research Projects (grant no. 2026WSJK171), the Science and Technology Research Program of Chongqing Municipal Education Commission (grant nos. KJQN202502805, KJQN202602801 and KJZD-M202502802), the 2025 Innovation Group Project of Chongqing Medical and Pharmaceutical College (grant no. YGZZK2025502), the Scientific Research Project of Chongqing Medical and Pharmaceutical College (grant nos. YGZRC2024104 and YGZ2022104) and the Technological Innovation Project of Shapingba District, Chongqing (grant no. 2025017)</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Cancer, a major global public health issue, accounted for 18.5 million new cases and 10.4 million deaths worldwide in 2023. It is projected to increase to 30.5 million new cases and 18.6 million deaths by 2050, and its high morbidity and mortality pose a severe threat to human health (<xref rid="b1-ol-33-1-15938" ref-type="bibr">1</xref>). Clinical treatment of various malignant tumors such as prostate cancer and leukemia is still confronted with plights including recurrent drug resistance, significant side effects and poor prognosis. Thus, the search for novel anticancer drugs with low toxicity, high efficacy, and wide availability has become a research hotspot in the medical and pharmaceutical fields (<xref rid="b2-ol-33-1-15938" ref-type="bibr">2</xref>). Natural products, by virtue of their advantages including structural diversity, broad biological activities and low toxicity and side effects, serve as an important source for the development of anticancer drugs (<xref rid="b3-ol-33-1-15938" ref-type="bibr">3</xref>). Furthermore, ethnic medicines embody the medicinal wisdom accumulated through long-term clinical practice and provide valuable clues for the discovery of novel anticancer drugs.</p>
<p><italic>Carpesium cernuum</italic> L. is a perennial herbaceous plant belonging to the genus <italic>Carpesium</italic> of the Asteraceae family. It is distributed in many regions worldwide and mainly grows in wastelands, hillsides and ditch banks in China, with abundant resource reserves. As a commonly used traditional ethnic medicine of the Miao nationality, the entire plant is used for medicinal purposes. It is bitter and pungent in taste and in TCM possesses multiple effects including inducing diaphoresis, clearing heat and detoxifying and dissipating blood stasis. It is often used for the treatment of stranguria, inflammation and other diseases (<xref rid="b4-ol-33-1-15938" ref-type="bibr">4</xref>). Its medicinal value has been officially included in the Quality Standards for Chinese Medicinal Materials and Ethnic Medicinal Materials of Guizhou Province, and it serves as an important medicinal ingredient in prepared Miao medicinal formulas (<xref rid="b5-ol-33-1-15938" ref-type="bibr">5</xref>). Furthermore, there are folk records of its application in treating sore pain, dysentery and other diseases. The long-term medicinal practice has laid a solid foundation for its modern pharmacological research.</p>
<p>Modern pharmacological studies have confirmed that extracts of <italic>C. cernuum</italic> possess broad biological activities, among which the antitumor activity is particularly prominent and has become a research focus in recent years (<xref rid="b6-ol-33-1-15938" ref-type="bibr">6</xref>). Previous studies have shown that extracts of <italic>C. cernuum</italic> exert significant inhibitory effects on various tumor cells, including multiple cancer types such as prostate cancer, leukemia, hepatocellular carcinoma and breast cancer. Their anticancer effects are mainly reflected in inhibiting tumor cell proliferation, arresting the cell cycle, inducing cell apoptosis and autophagy and suppressing tumor cell migration and invasion, among other aspects (<xref rid="b7-ol-33-1-15938" ref-type="bibr">7</xref>). Further studies have revealed that its anticancer effects are closely associated with the regulation of key signaling pathways such as phosphatidylinositol 3-kinase-protein kinase b-mammalian target of rapamycin (PI3K/Akt/mTOR) and Hippo. These signaling pathways play a central role in tumor initiation, progression, and metastasis, thereby providing an important direction for the in-depth exploration of the anticancer mechanisms of <italic>C. cernuum</italic> (<xref rid="b8-ol-33-1-15938" ref-type="bibr">8</xref>).</p>
<p>The present study systematically summarized the research progress on the anticancer chemical constituents, pharmacological effects, and action targets of <italic>C. cernuum</italic>, combines the molecular network of its anticancer mechanisms. The present study strictly stratified existing anticancer evidence by research object (crude extract/active fraction/monomeric compound) and research model (<italic>in vitro</italic> cell assay/<italic>in vivo</italic> animal experiment/network pharmacology prediction) and further evaluated the reliability and limitations of each type of evidence. It aimed to provide scientific references for the further development and utilization of <italic>C. cernuum</italic>, the development of novel anticancer drugs and its clinical application, thereby promoting the research on this traditional medicinal plant toward a deeper and broader application-oriented direction in the field of anticancer research.</p>
</sec>
<sec>
<label>2.</label>
<title>Search method</title>
<p>A standardized and transparent literature retrieval and screening framework was adopted in this narrative review to guarantee the comprehensiveness, accuracy and reproducibility of the included evidence. The detailed methodological procedures are presented below. i) Literature databases and search period: Relevant published studies were collected from PubMed (hpubmed.ncbi.nlm.nih.gov/), ScienceDirect (sciencedirect.com), Web of Science (webofscience.com/wos), and China National Knowledge Infrastructure (CNKI, <uri xlink:href="https://www.cnki.net/">http://www.cnki.net/</uri>), with a publication time range from January 2000 to August 2025. ii) Search terms: Boolean search strings were constructed based on core keywords: (&#x2018;<italic>Carpesium cernuum</italic>&#x2019; OR &#x2018;<italic>Carpesium cernuum</italic> L.&#x2019;) and (&#x2018;chemical constituent&#x2019; OR &#x2018;sesquiterpenoid&#x2019; OR &#x2018;natural product&#x2019;) and (&#x2018;anticancer&#x2019; OR &#x2018;antitumor&#x2019; OR &#x2018;cancer cell&#x2019;) and (&#x2018;pharmacology&#x2019; OR &#x2018;mechanism&#x2019; OR &#x2018;signaling pathway&#x2019;). Corresponding synonyms and variant spellings were additionally supplemented to achieve maximal literature coverage. iii) Inclusion criteria: Original research articles and eligible reviews focusing on the chemical isolation, structural identification, anticancer pharmacological activities and molecular mechanisms of <italic>C. cernuum</italic> were enrolled. Studies with explicitly defined compound structures, molecular formulas, molecular weights and reproducible anticancer experimental data were prioritized for data tabulation and mechanistic discussion. All included studies were categorized into four evidence levels: Level 1 (<italic>in vivo</italic> animal experiments), Level 2 (<italic>in vitro</italic> cell assays of isolated monomeric compounds), Level 3 (<italic>in vitro</italic> cell assays of crude extracts/fractions) and Level 4 (network pharmacology/bioinformatics prediction without experimental verification). iv) Exclusion criteria: Letters, conference abstracts, case reports, duplicate publications, non-Chinese and non-English studies, as well as literature with incomplete experimental data or ambiguous compound information were excluded. v) Literature screening and data extraction: All retrieved records were initially screened by titles and abstracts, followed by rigorous full-text evaluation. Screening and data extraction were independently completed by two authors, and any inconsistencies were resolved through group discussion or consultation with a third author. Furthermore, the reference lists of eligible publications were manually screened to identify and supplement potential missing studies. vi) Data standardization for tables: All compound-related information in <xref rid="tI-ol-33-1-15938" ref-type="table">Table I</xref>, <xref rid="tII-ol-33-1-15938" ref-type="table">Table II</xref>, <xref rid="tIII-ol-33-1-15938" ref-type="table">Table III</xref>, <xref rid="tIV-ol-33-1-15938" ref-type="table">Table IV</xref>, including compound name, classification, molecular formula and molecular weight, was uniformly verified and revised in accordance with authoritative spectral data and standard nominal mass calculation criteria. This process eliminated formulaic and numerical errors, ensuring consistent and reliable data accuracy throughout the manuscript.</p>
</sec>
<sec>
<label>3.</label>
<title>Chemical constituents and pharmacological studies of C. cernuum</title>
<sec>
<title/>
<sec>
<title>Chemical constituents in C. cernuum</title>
<p>A total of 109 compounds have been isolated and identified from <italic>C. cernuum</italic>, mainly including sesquiterpenoids, diterpenoids, flavonoids, and other classes of compounds. Among these, sesquiterpenoids are considered to be the major bioactive constituents of <italic>C. cernuum</italic> The chemical compound name, compound type, molecular formula and molecular weight were included in <xref rid="tI-ol-33-1-15938" ref-type="table">Table I</xref>, <xref rid="tII-ol-33-1-15938" ref-type="table">Table II</xref>, <xref rid="tIII-ol-33-1-15938" ref-type="table">Table III</xref>, <xref rid="tIV-ol-33-1-15938" ref-type="table">Table IV</xref> based on related references respectively (<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>&#x2013;<xref rid="b75-ol-33-1-15938" ref-type="bibr">75</xref>).</p>
</sec>
<sec>
<title>Sesquiterpenoids</title>
<p>A total of 60 sesquiterpenoids have been isolated and identified from <italic>C. cernuum</italic> (<xref rid="tI-ol-33-1-15938" ref-type="table">Table I</xref>) and their detailed structural types shown in <xref rid="f1-ol-33-1-15938" ref-type="fig">Figs. 1</xref> (compounds 1&#x2013;30) and 2 (compounds 31&#x2013;60).</p>
</sec>
<sec>
<title>Diterpenoids</title>
<p>A total of nine diterpenoids have been isolated and identified from <italic>C. cernuum</italic>, with their detailed names and information listed in <xref rid="tII-ol-33-1-15938" ref-type="table">Table II</xref> and their detailed structural types shown in <xref rid="f3-ol-33-1-15938" ref-type="fig">Fig. 3</xref> (compounds 61&#x2013;69).</p>
</sec>
<sec>
<title>Flavonoids</title>
<p>A total of three flavonoids have been isolated and identified from <italic>C. cernuum</italic>, with their detailed names and information listed in <xref rid="tIII-ol-33-1-15938" ref-type="table">Table III</xref> and their detailed structural types shown in <xref rid="f4-ol-33-1-15938" ref-type="fig">Fig. 4</xref> (compounds 70&#x2013;72).</p>
</sec>
<sec>
<title>Other classes of compounds</title>
<p>A total of 37 other classes of compounds have been isolated and identified from <italic>C. cernuum</italic>, with their detailed names and information listed in <xref rid="tIV-ol-33-1-15938" ref-type="table">Table IV</xref> and their detailed structural types shown in <xref rid="f5-ol-33-1-15938" ref-type="fig">Fig. 5</xref> (compounds 73&#x2013;92) and <xref rid="f6-ol-33-1-15938" ref-type="fig">Fig. 6</xref> (compounds 93&#x2013;109).</p>
</sec>
<sec>
<title>Anticancer pharmacological effects of C. cernuum</title>
<p>To clarify the evidence quality of existing anticancer research, this subsection systematically re-analyzes the anticancer effects of <italic>C. cernuum</italic> by distinguishing research materials (crude extract/fraction/monomer) and experimental models (cell/animal). Overall, current anticancer evidence is dominated by <italic>in vitro</italic> cell experiments, with limited <italic>in vivo</italic> validation and no clinical data, and the research depth varies significantly across different cancer types. Consistent with existing preclinical findings, <italic>C. cernuum</italic> and its active constituents exhibit tentative anticancer activity in <italic>in vitro</italic> and partial <italic>in vivo</italic> models, which merits further systematic verification.</p>
</sec>
<sec>
<title>Anti-prostate cancer effects</title>
<p>As an important component of traditional Miao medicine, the anti-prostate cancer pharmacological effects of <italic>C. cernuum</italic> have been fully verified by <italic>in vitro</italic> experiments and have demonstrated promising preclinical anticancer potential (<xref rid="b2-ol-33-1-15938" ref-type="bibr">2</xref>). Notably, existing anti-prostate cancer evidence for <italic>C. cernuum</italic> is derived from two types of research materials: Aqueous crude extract (Level 3 evidence) and purified monomeric sesquiterpenoids (ineupatolide, incaspitolide A, Level 2 evidence), with all validations based on <italic>in vitro</italic> PC3 and DU-145 cell models; no <italic>in vivo</italic> animal experiments have been reported. Modern pharmacological studies have shown that the anti-prostate cancer activity of <italic>C. cernuum</italic> is mainly achieved through its extracts and bioactive constituents <italic>via</italic> multiple pathways, including inhibiting cell proliferation, inducing cell apoptosis, and suppressing migration and invasion. Moreover, its mechanism is closely associated with the regulation of key signaling pathways (<xref rid="b4-ol-33-1-15938" ref-type="bibr">4</xref>). The aqueous extract of <italic>C. cernuum</italic> (AECC) significantly inhibits the proliferation of prostate cancer PC3 cells in a concentration- and time-dependent manner, with a progressive decrease in cell survival rate (statistically significant vs. control group). AECC induces late apoptosis of PC3 cells, as confirmed by Hoechst 33258 staining and flow cytometry, which is associated with regulating apoptosis-related proteins: It upregulates the mRNA and protein levels of cysteine-aspartic acid protease (caspase)-3 and Bcl-2-associated X protein (Bax), while downregulating B-cell lymphoma/leukemia (Bcl-2) expression (<xref rid="b76-ol-33-1-15938" ref-type="bibr">76</xref>).</p>
<p>Regarding the migration and invasion abilities of tumor cells, Transwell assay showed that AECC significantly reduced the number of migrated and invaded PC3 cells. This effect is associated with the inhibition of the &#x03B2;-catenin signaling pathway (<xref rid="b2-ol-33-1-15938" ref-type="bibr">2</xref>), which can downregulate the mRNA and protein expression of &#x03B2;-catenin and its downstream targets, including matrix metalloproteinases (MMPs) 7 and myelocytomatosis virus oncogene (c-Myc).</p>
<p>Taken together, <italic>C. cernuum</italic> exerts anti-prostate cancer effects through a multi-targeted and multi-mechanistic mode of action. However, the lack of <italic>in vivo</italic> animal model verification greatly weakens the reliability of existing conclusions and the effective concentration range of crude extracts and monomers <italic>in vitro</italic> cannot be directly converted for <italic>in vivo</italic> application, indicating that its actual <italic>in vivo</italic> efficacy and clinical translational value remain to be further validated.</p>
</sec>
<sec>
<title>Anti-pancreatic cancer effects</title>
<p>Anti-pancreatic cancer research of <italic>C. cernuum</italic> is highly specific, with all valid evidence derived from the purified monomer carabrone (carabrane-type sesquiterpenoid, Level 2 <italic>in vitro</italic> cell evidence), and no relevant activity evaluation of crude extracts or fractions has been reported. No <italic>in vivo</italic> animal experiments or clinical studies are available.</p>
<p>Carabrone, a sesquiterpenoid isolated from <italic>C. cernuum</italic>, has previously been demonstrated to possess multiple antitumor activities, including anti-hepatocellular carcinoma and anti-breast cancer effects. The present review further revealed its potential anti-pancreatic cancer activity in preclinical cell models (<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>). Cell proliferation inhibition assay showed that carabrone exerted inhibitory effects on the proliferation of multiple pancreatic cancer cell lines in a dose-dependent manner, among which it exhibited the most prominent inhibitory effect on human pancreatic ductal adenocarcinoma SW1990 cells (<xref rid="b78-ol-33-1-15938" ref-type="bibr">78</xref>). It can effectively impair the colony proliferation capacity of pancreatic cancer cells. Furthermore, colony formation assay demonstrated that it exerted a significant inhibitory effect on cell colony formation, with its potency comparable to that of paclitaxel, a clinically commonly used anticancer drug, thereby exhibiting favorable antiproliferative activity (<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>,<xref rid="b79-ol-33-1-15938" ref-type="bibr">79</xref>). Immunofluorescence confirmed that this compound downregulated the protein expression of MMP2 and MMP9, which are closely associated with tumor migration (<xref rid="b80-ol-33-1-15938" ref-type="bibr">80</xref>). This undermines the molecular basis for tumor cell invasion, thereby reducing the metastatic potential of pancreatic cancer cells and providing experimental support for inhibiting pancreatic cancer metastasis.</p>
<p>Taken together, carabrone derived from <italic>C. cernuum</italic> exerts anti-pancreatic cancer activity through a multi-targeted and multi-pathway mode of action. It exhibits clear <italic>in vitro</italic> inhibitory effects, and as a natural plant-derived compound, it possesses favorable biocompatibility in cell-level experiments. Nevertheless, the single-cell-model limitation and absence of <italic>in vivo</italic> verification restrict its further pharmacological evaluation and drug development.</p>
</sec>
<sec>
<title>Antileukemic effects</title>
<p>Anti-leukemia evidence of <italic>C. cernuum</italic> includes two levels: ethanol crude extract (Level 3 evidence, K562 cell model) and purified monomer cernuumolide J [Level 2 evidence, human erythroleukemia (HEL) cell model], all based on <italic>in vitro</italic> cell experiments without <italic>in vivo</italic> validation.</p>
<p>Numerous modern experiments have verified that <italic>C. cernuum</italic>, its extracts and bioactive components exert potential pharmacological activities against leukemia in <italic>in vitro</italic> models. The underlying mechanisms mainly include inducing apoptosis, suppressing proliferation and modulating relevant signaling pathways in leukemia cells (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>). The ethanol extract of <italic>C. cernuum</italic> exerts a significant inhibitory effect on human chronic myeloid leukemia (CML) K562 cells. Yan <italic>et al</italic> (<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>) demonstrated that within a certain concentration range, this ethanol extract inhibited the proliferation of K562 cells in a dose-dependent manner. Furthermore, Hoechst 33258 staining revealed that K562 cells treated with this extract exhibited typical apoptotic morphological characteristics, including chromatin condensation and nuclear fragmentation. Moreover, flow cytometry analysis showed that the apoptotic rate of K562 cells increased significantly with the elevation of extract concentration. Mechanistic studies have confirmed that this ethanol extract of <italic>C. cernuum</italic> can downregulate Bcl-2 expression, upregulate Bax expression and activate the caspase-3 signaling pathway, thereby initiating the apoptotic program of leukemia cells (<xref rid="b82-ol-33-1-15938" ref-type="bibr">82</xref>). Wei <italic>et al</italic> (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>) demonstrated that cernuumolide J, an extract of <italic>C. cernuum</italic>, exerted a significant inhibitory effect on human erythroleukemia (HEL) cells. Its core mechanism involves regulating the JAK2/STAT3 and the mitogen-activated protein kinase (MAPK) signaling pathway. On the one hand, it induces HEL cell cycle arrest at the G<sub>2</sub>/M phase to inhibit their abnormal proliferation. On the other hand, it triggers the apoptotic program via decreased mitochondrial membrane potential (&#x0394;&#x03A8;m), thereby reducing the viability of tumor cells.</p>
<p>Taken together, <italic>C. cernuum</italic> and its bioactive constituents exert anti-leukemic effects through multiple pathways. Current studies only confirm <italic>in vitro</italic> anti-leukemic activity and the <italic>in vivo</italic> efficacy, toxicity and pharmacokinetic characteristics remain unclear, which limits the comprehensive evaluation of its anti-leukemic application potential (<xref rid="b83-ol-33-1-15938" ref-type="bibr">83</xref>,<xref rid="b84-ol-33-1-15938" ref-type="bibr">84</xref>).</p>
</sec>
<sec>
<title>Anti-breast cancer effects</title>
<p>Anti-breast cancer evidence is mainly derived from ethyl acetate active fraction of <italic>C. cernuum</italic> 95&#x0025; ethanol extract (Level 3 evidence), verified by MDA-MB-231 and MCF7 breast cancer cell models; no single active monomer has been confirmed for targeted anti-breast cancer activity, and no <italic>in vivo</italic> experiments have been conducted.</p>
<p>The pharmacological effects of <italic>C. cernuum</italic> against breast cancer have been clearly confirmed by modern pharmacological studies, providing important evidence for the development of new antitumor drugs. The extracts of this plant and its monomeric components exhibit significant inhibitory activity against breast cancer cells. Feng <italic>et al</italic> (<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>) isolated and identified compounds from the ethyl acetate fraction of the 95&#x0025; ethanol extract of <italic>C. cernuum</italic>, which exhibited potent cytotoxic activity against human triple-negative breast cancer (TNBC) MDA-MB-231 cells with an IC<sub>50</sub> value of 6.80 &#x00B5;mol/l. Dang <italic>et al</italic> (<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>) further confirmed that the extract of <italic>C. cernuum</italic> (CCE) exhibited the most significant antiproliferative activity against MDA-MB-231 cells and was also effective against hormone-dependent human breast cancer (MCF7) cells. Its mechanism is associated with inhibiting DNA synthesis, downregulating the expression of key cell proliferation genes, namely epidermal growth factor receptor (EGFR) and cyclin-dependent kinase 2 (CDK2), and simultaneously blocking the activation of phosphorylated (p-) EGFR induced by epidermal growth factor (EGF).</p>
<p>In terms of anti-breast cancer metastasis, <italic>C. cernuum</italic> exerts significant inhibitory effects on TNBC metastasis by regulating cell adhesion pathways and metastasis-related genes. Transcriptomic analysis indicated that the active sesquiterpene lactones from <italic>C. cernuum</italic> significantly enriched the cell adhesion molecules (CAMs) pathway (<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>), upregulated the tumor metastasis suppressor gene tissue inhibitor of metalloproteinase-1 (TIMP1), and downregulated pro-metastatic genes such as MMP9, cluster of differentiation 44 (CD44) and collagen type IV &#x03B1; 2 chain (COL4A2). By balancing the MMP9/TIMP1 signaling axis, the active constituents of <italic>C. cernuum</italic> inhibit extracellular matrix (ECM) degradation (<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>), thereby markedly suppressing the migration and invasion capacities of MDA-MB-231 cells (<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>). The core bioactive components of <italic>C. cernuum</italic> are sesquiterpene lactones, which recapitulate the anti-metastatic performance of the botanical extract and constitute the material basis for its anti-breast cancer activity.</p>
<p>In addition, previous studies have confirmed that sesquiterpenoid monomers from <italic>C. cernuum</italic> may block cancer cell proliferation by inhibiting associated signaling pathways. Combined with their dual inhibitory effects on the proliferation and metastasis of breast cancer cells, as well as definite molecular targets, this suggests that <italic>C. cernuum</italic> extracts and sesquiterpene lactone components have preliminary potential for development into anti-breast cancer drug candidates, especially for TNBC metastasis intervention, providing a novel candidate direction for clinical breast cancer treatment (<xref rid="tV-ol-33-1-15938" ref-type="table">Table V</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<label>4.</label>
<title>Analysis of action targets of C. cernuum</title>
<sec>
<title/>
<sec>
<title>Regulation of the PI3K/Akt/mTOR signaling axis by C. cernuum</title>
<p>The core anti-prostate cancer bioactive constituents of <italic>C. cernuum</italic> are ineupatolide and incaspitolide A, both of which are germacrane-type sesquiterpenes. Their core mechanism lies in the targeted regulation of the PI3K/Akt/mTOR signaling axis, exerting antitumor effects through multi-node inhibition. The PI3K/Akt/mTOR signaling axis is a key pathway regulating cell proliferation, cell cycle, apoptosis and autophagy (<xref rid="b85-ol-33-1-15938" ref-type="bibr">85</xref>) and the bioactive constituents of <italic>C. cernuum</italic> exert their effects by directly acting on the core molecules of this pathway. First, ineupatolide and incaspitolide A can specifically bind to the catalytic subunit of PI3K, downregulate the phosphorylation level of PI3K (p-PI3K), block its ability to convert phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3), and further inhibit the phosphorylation and activation of downstream Akt (p-Akt), forming a key block at the upstream of the pathway (<xref rid="b86-ol-33-1-15938" ref-type="bibr">86</xref>). Following the inhibition of Akt phosphorylation, its ability to activate downstream mTOR is attenuated, resulting in a significant decrease in the level of phosphorylated mTOR (p-mTOR). As the core kinase of the pathway, inhibition of mTOR activity directly affects its downstream substrates. On the one hand, they downregulate the phosphorylation of ribosomal protein S6 kinase 70 kDa polypeptide 1 and proline-rich Akt substrate of 40 kDa, thereby inhibiting ribosome biogenesis and the transcription of cell proliferation-related genes (<xref rid="b87-ol-33-1-15938" ref-type="bibr">87</xref>). On the other hand, they downregulate the protein expression of sequestosome 1, a protein primarily functioning as an autophagic adaptor rather than a nucleolar-specific protein, promote the conversion of microtubule-associated protein 1A/1B-light chain 3-I (LC3-I) to LC3-II, enhance autophagolysosome formation, and thereby induce autophagic cell death of tumor cells. Inhibition of this signaling axis triggers downstream cascade regulation: at the cell cycle level, it downregulates the protein expression of cyclin-dependent kinase 1 (CDK1), CDK2 and cyclin A2 (CCNA2), upregulates P53 expression, and arrests prostate cancer cells at the S phase or G<sub>2</sub>/M phase. At the apoptotic level, it inhibits the anti-apoptotic effects of X-linked inhibitor of apoptosis protein and Bcl-2, promotes the expression of Bax, cleaved-caspase-3 (activated/cleaved form), and cleaved-PARP, thereby initiating the mitochondria-dependent apoptotic pathway (<xref rid="b88-ol-33-1-15938" ref-type="bibr">88</xref>). At the migration and invasion level, by inhibiting PI3K-Akt-mediated MMPs activity, it reduces the migration and invasion abilities of human prostate cancer cell lines PC-3 and human prostate cancer cell line DU-145 (<xref rid="b89-ol-33-1-15938" ref-type="bibr">89</xref>).</p>
<p>This pathway has been validated by network pharmacology, transcriptomics and <italic>in vitro</italic> and <italic>in vivo</italic> experiments. Notably, all pathway verification data are derived from <italic>in vitro</italic> cell models, and the <italic>in vivo</italic> regulatory effect of the PI3K/Akt/mTOR axis remains to be confirmed. The bioactive constituents regulate the phosphorylation levels of various nodes in the signaling axis in a dose-dependent manner, forming a complete regulatory chain: PI3K-Akt inhibition, mTOR inactivation, proliferation inhibition &#x002B; apoptosis induction &#x002B; autophagy activation, which provides clear molecular mechanism support for <italic>C. cernuum</italic> potential candidate for anti-prostate cancer preclinical research (<xref rid="f7-ol-33-1-15938" ref-type="fig">Fig. 7</xref>).</p>
</sec>
<sec>
<title>Regulation of the Hippo signaling pathway by the bioactive constituent carabrone</title>
<p>Carabrone is a carabrane-type sesquiterpenoid isolated from <italic>C. cernuum</italic>, a plant belonging to the genus <italic>Carpesium</italic>. It exhibits potent <italic>in vitro</italic> anti-pancreatic cancer activity and its mechanism of action is closely associated with the precise regulation of the Hippo signaling pathway.</p>
<p>The Hippo signaling pathway is a key pathway regulating cell proliferation, migration and apoptosis and its aberrant activation or silencing is closely associated with tumor initiation and progression (<xref rid="b90-ol-33-1-15938" ref-type="bibr">90</xref>). Previous studies have shown that carabrone exerts its effects through the bidirectional regulation of core molecules in the Hippo signaling pathway. On the one hand, it specifically upregulates the expression of casein kinase 1&#x03B5; (CSNK1E). On the other hand, it significantly downregulates the expression of WW domain-containing transcription regulator 1 (WWTR1). These two molecules are precisely co-involved in the regulation of cell proliferation, forming a synergistic regulatory network that directly inhibits the proliferation and colony-forming ability of pancreatic cancer cells, thereby activating the antitumor effects of the Hippo signaling pathway (<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>).</p>
<p>Mediated by the Hippo signaling pathway, carabrone can also impair the cell migration potential: Activation of the pathway by carabrone inhibits the binding of core effector molecules Yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ) to TEA domain transcription factors, thereby reducing the expression and phosphorylation modification of migration-related protein MMP2. Given the bidirectional regulatory relationship between MMP2 and MMP9, the inhibition of MMP2 activity further downregulates the function of MMP9, ultimately resulting in a significant inhibition of pancreatic cancer cell migration (<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>).</p>
<p>Meanwhile, activation of this pathway can induce G<sub>2</sub> phase cell cycle arrest in pancreatic cancer cells <italic>via</italic> the core component MOB kinase activator 1 (MOB1) and this arrest is accompanied by the phosphorylation modification of cell cycle-related proteins, which effectively prevents cells from entering the mitotic phase (<xref rid="b91-ol-33-1-15938" ref-type="bibr">91</xref>). Simultaneously, regulation of this pathway promotes an increase in reactive oxygen species (ROS) levels and triggers a decrease in &#x0394;&#x03A8;m an abnormality that is one of the key characteristics of ferroptosis. Ultimately, building on apoptosis, the pathway further forms crosstalk and synergy with the ferroptosis pathway, thereby enhancing its antitumor efficacy.</p>
<p>In summary, carabrone activates the Hippo signaling pathway by upregulating CSNK1E and downregulating WWTR1, thereby inhibiting the malignant progression of pancreatic cancer cells through multiple aspects including cell proliferation, migration, cell cycle regulation and cell death. All mechanistic conclusions are limited to the <italic>in vitro</italic> SW1990 cell model and the universality and <italic>in vivo</italic> applicability of the Hippo pathway regulation need verification. Elucidation of this mechanism not only reveals the core molecular targets of carabrone against pancreatic cancer but also provides important theoretical support for the development of anti-pancreatic cancer drugs derived from natural products that target the Hippo signaling pathway and possesses potential clinical translational value (<xref rid="f8-ol-33-1-15938" ref-type="fig">Fig. 8</xref>).</p>
</sec>
<sec>
<title>Regulation of the Wnt/&#x03B2;-catenin) signaling pathway by the crude extract of C. cernuum</title>
<p>The crude extract of <italic>C. cernuum</italic> enhances GSK-3&#x03B2; activity to exert bidirectional regulation on key genes of the Wnt/&#x03B2;-catenin signaling pathway and the core regulatory complex adenomatous polyposis coli/axis inhibition protein (APC/Axin), thereby forming a molecular network that synergistically antagonizes prostatic hyperplasia. As core negative regulators of the Wnt signaling pathway, APC and Axin can form a stable complex to promote the phosphorylation and degradation of &#x03B2;-catenin, thereby maintaining pathway homeostasis (<xref rid="b92-ol-33-1-15938" ref-type="bibr">92</xref>). Meanwhile, the crude extract interferes with the function of this complex, laying the foundation for subsequent gene regulation.</p>
<p>Crude extract of <italic>C. cernuum</italic> promotes the expression of the pathway inhibitor secreted frizzled-related protein 2 (SFRP2) as well as apoptosis-related genes, including &#x03B2;-catenin and c-Myc. Mechanistically, the crude extract of <italic>C. cernuum</italic> inhibits the degradative activity of the APC/Axin complex, reduces the phosphorylation-mediated loss of &#x03B2;-catenin, resulting in its moderate accumulation in the cytoplasm. Meanwhile, as a Wnt ligand-competing binding protein, secreted SFRP2 may blocks the interaction between Wnt ligands and the receptor frizzled class receptor 2 (FZD2), directly inhibiting the aberrant activation of the pathway. This forms synergy with the regulation of the APC/Axin complex (<xref rid="b93-ol-33-1-15938" ref-type="bibr">93</xref>). Notably, the upregulation of &#x03B2;-catenin here does not mediate a pro-proliferative effect but rather synergizes with c-Myc to initiate the apoptotic program. This is consistent with apoptotic characteristics such as the formation of apoptotic bodies and DNA fragmentation observed in cellular morphological studies, further indicating that &#x03B2;-catenin can switch to the apoptotic regulatory pathway to exert its function following the inhibition of the APC/Axin complex.</p>
<p>In terms of gene downregulation, the crude extract of <italic>C. cernuum</italic> can significantly inhibit the expression of Cyclin D1, a pro-proliferative target gene downstream of the Wnt/&#x03B2;-catenin signaling pathway (<xref rid="b7-ol-33-1-15938" ref-type="bibr">7</xref>,<xref rid="b94-ol-33-1-15938" ref-type="bibr">94</xref>). As a key molecule in cell cycle regulation, Cyclin D1 is indirectly regulated by the APC/Axin-&#x03B2;-catenin pathway. The crude extract of <italic>C. cernuum</italic> indirectly blocks the transcriptional activation of Cyclin D1 by regulating the function of this complex, thereby effectively blocking the cell cycle progression and inhibiting the aberrant proliferation of prostatic hyperplasia cells. Meanwhile, although the expression of FZD2, an upstream receptor of the pathway, and dickkopf-related protein 1 (DKK1), a signal transduction molecule, exhibits slight fluctuations, it remains consistently at a low level. This further weakens the pro-proliferative signal input of the pathway and forms a synergy with the APC/Axin-mediated regulation of &#x03B2;-catenin, thereby synergistically enhancing the anti-proliferative effect (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>) (<xref rid="f9-ol-33-1-15938" ref-type="fig">Fig. 9</xref>).</p>
<p>Regulation of the mitogen-activated protein kinases (MAPKs) signaling pathway by Cernuumolide J, a bioactive constituent isolated from <italic>C. cernuum</italic>. Cernuumolide J exerts anti-proliferative and pro-apoptotic effects on leukemia cells by targeting and regulating the MAPKs signaling pathway, with the core mechanisms as follows:</p>
<p>The three major subfamilies of the MAPKs pathway, extracellular signal-regulated kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38 MAPK, are the key targets of cernuumolide J, with significant selectivity in its regulation: Cernuumolide J can significantly downregulate the phosphorylation level of ERK (p-ERK), block the pro-proliferative signaling mediated by ERK, and thereby impair the survival advantage of leukemia cells. Meanwhile, it specifically activates the phosphorylation of JNK and p38 MAPK (p-JNK and p-p38), initiating cascade reactions that lead to pro-apoptosis and cell cycle arrest (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>).</p>
<p>In downstream effects, the activated JNK/p38 pathway exerts its functions through multiple core mechanisms: First, it regulates key cell cycle molecules and promotes the upregulation of DNA damage-related protein checkpoint kinase 2, tumor suppressor protein p53, and cell cycle inhibitor p21. Simultaneously, it inhibits the activity of the oncoprotein c-Myc, cell cycle driver protein Cyclin B1, CDK1 and phosphorylated cell division cycle 2 (p-CDC2), leading to the accumulation of DNA damage in HEL cells, arresting them at the G<sub>2</sub>/M phase and blocking their aberrant proliferation. Second, it induces the release of intracellular ROS, decreases the &#x0394;&#x03A8;m and impairs mitochondrial homeostasis, thereby activating the cysteine-dependent aspartate-specific protease (caspase) apoptotic pathway, upregulating the protein expression of cleaved caspase-3, cleaved caspase-9 and cleaved poly (ADP-ribose) polymerase (cleaved-PARP) and initiating programmed cell death (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>,<xref rid="b95-ol-33-1-15938" ref-type="bibr">95</xref>).</p>
<p>Furthermore, the regulation of the MAPKs pathway by cernuumolide J exerts a synergistic effect with the inhibition of the JAK2/STAT3 pathway. Additionally, its apoptosis-inducing effect can be significantly reversed by the pan-caspase inhibitor z-val-ala-asp (OMe)-fmk (Z-VAD-FMK), confirming that the caspase-dependent apoptotic pathway is a key executive component downstream of the MAPK signaling pathway (<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>). Taken together, cernuumolide J adopts a dual regulatory mode of inhibiting ERK-mediated pro-proliferation and activating JNK/p38-mediated pro-apoptosis/cell cycle arrest, orchestrates the ROS-&#x0394;&#x03A8;m-caspase axis and the cell cycle regulatory network, thereby providing core mechanistic support for its potential as a novel anti-leukemia drug candidate worthy of further exploration (<xref rid="f10-ol-33-1-15938" ref-type="fig">Fig. 10</xref>). This mechanism is only validated in HEL leukemia cell model, and whether it is universal in other leukemia cell lines or <italic>in vivo</italic> needs further exploration.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<label>5.</label>
<title>Discussion</title>
<p>As a perennial herbaceous plant belonging to the genus <italic>Carpesium</italic> of the family <italic>Asteraceae</italic> (<xref rid="b60-ol-33-1-15938" ref-type="bibr">60</xref>), <italic>C. cernuum</italic> occupies an important position in the traditional medicine systems of ethnic minorities such as the Miao nation (<xref rid="b4-ol-33-1-15938" ref-type="bibr">4</xref>,<xref rid="b96-ol-33-1-15938" ref-type="bibr">96</xref>). Its traditional efficacies of heat-clearing, detoxification, detumescence and analgesia have been validated by long-term folk medicinal application, which provides solid traditional empirical basis for modern pharmacological mechanism research (<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>). With the growing attention paid to natural products in the field of novel anticancer drug development, <italic>C. cernuum</italic> has gradually emerged as a research focus in this area owing to its unique chemical composition and preliminarily reported anti-tumor activity. For decades, natural products have been regarded as an important origin for anticancer drug development due to their inherent merits in structure, biocompatibility and safety profile (<xref rid="b97-ol-33-1-15938" ref-type="bibr">97</xref>). <italic>C. cernuum</italic> harbors diverse bioactive constituents, which lay a solid material foundation for further exploring its potential anticancer potential (<xref rid="b60-ol-33-1-15938" ref-type="bibr">60</xref>). Currently, anticancer research on <italic>C. cernuum</italic> has achieved phased progress in aspects such as chemical constituent identification, pharmacological activity verification and molecular mechanism elucidation. Notably, existing evidence presents prominent hierarchical limitations and uneven research depth across studies: All available anticancer outcomes are exclusively supported by <italic>in vitro</italic> cell-based experiments, while high-level <italic>in vivo</italic> animal validation and clinical evidence remain absent; the reliability of research findings varies substantially across different cancer types, and the material basis and molecular mechanisms underlying several observed bioactivities remain incompletely clarified.</p>
<p>The anticancer potential of <italic>C. cernuum</italic> is derived from its complex and diverse chemical composition system, among which sesquiterpenoids play a crucial role. As secondary metabolites formed through the long-term evolution of plants, the chemical constituents of <italic>C. cernuum</italic> encompass multiple categories such as sesquiterpenoids, diterpenoids, flavonoids, aromatic compounds and sterols (<xref rid="b60-ol-33-1-15938" ref-type="bibr">60</xref>). These substances (plant sterols) can yield 5,7-dienal sterols, which can be converted into bioactive secosteroidal products upon exposure to UVB irradiation (<xref rid="b98-ol-33-1-15938" ref-type="bibr">98</xref>). It is also reported that secosteroids can affect circadian rhythm (<xref rid="b99-ol-33-1-15938" ref-type="bibr">99</xref>). Such a diverse composition endows it with the inherent advantage of &#x2018;multi-component synergistic effect&#x2019;. Among these constituents, sesquiterpenoids are widely recognized as core bioactive compounds with anticancer-related carriers, exhibiting rich structural diversity including germacrane-type, carabrane-type, guaiiane-type and other diverse backbone structures. Different structural types of sesquiterpenoids participate in the anti-tumor process through their respective targets. Unlike the single structural feature of chemically synthesized anticancer drugs, the structural diversity of sesquiterpenoids from <italic>C. cernuum</italic> derived sesquiterpenoids enables potential interactions with multiple biological targets in tumor cells (<xref rid="b100-ol-33-1-15938" ref-type="bibr">100</xref>), which may help alleviate the tumor drug resistance commonly induced by single-target therapeutic agents. This characteristic is highly consistent with the &#x2018;multi-target, multi-pathway&#x2019; anticancer mode of action of natural products (<xref rid="b101-ol-33-1-15938" ref-type="bibr">101</xref>). Furthermore, although flavonoids, diterpenoids and phenolic acids are present in relatively low amounts, they are not superfluous. Instead, they may further enhance the overall anticancer effect through mechanisms such as regulating the tumor microenvironment, improving the bioavailability of core bioactive constituents, or synergistically regulating signaling pathways (<xref rid="b60-ol-33-1-15938" ref-type="bibr">60</xref>). Such a multi-component coordinated and synergistic chemical system is an important characteristic that distinguishes <italic>C. cernuum</italic> from single chemical drugs and also provides important theoretical basis for subsequent evaluation of its potential value as a compound anticancer preparation candidate (<xref rid="b102-ol-33-1-15938" ref-type="bibr">102</xref>). In terms of anticancer pharmacological effects, <italic>C. cernuum</italic> and its bioactive constituents exhibit preliminary evidence of broad-spectrum antitumor inhibitory activity in preclinical cell models, exerting significant regulatory effects on various clinically common malignant tumors. Its mechanism spans multiple key links in tumor initiation and progression. For prostate cancer, <italic>C. cernuum</italic> extract achieves multi-dimensional regulation of tumor cell proliferation, apoptosis, migration and invasion by regulating key signaling pathways. It not only inhibits the aberrant proliferation of tumor cells but also initiates the apoptotic program, while reducing the metastatic potential of tumor cells, thereby forming a comprehensive anti-tumor effect at the cellular level (<xref rid="b90-ol-33-1-15938" ref-type="bibr">90</xref>). In pancreatic cancer treatment research, specific sesquiterpenoid components from <italic>C. cernuum</italic> exhibit prominent anti-tumor activity <italic>in vitro</italic> assays. They can not only effectively inhibit the proliferation capacity of pancreatic cancer cell populations but also disrupt the molecular basis of cancer cell invasion by downregulating the expression of tumor migration-related MMPs, thereby providing a research direction for inhibiting the metastasis and spread of pancreatic cancer (<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>). For leukemia, the extracts and bioactive constituents of <italic>C. cernuum</italic> mainly exert their effects through mechanisms such as activating apoptotic signaling pathways and inducing cell cycle arrest. They can induce typical apoptotic morphological characteristics in leukemia cells while inhibiting their aberrant proliferation, thereby representing a candidate for further preclinical investigation for leukemia treatment (<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>). In breast cancer research, the extracts and monomeric constituents of <italic>C. cernuum</italic> exhibit inhibitory activity against different subtypes of breast cancer cells. They show particular potential in inhibiting the metastasis of triple-negative breast cancer, with the underlying mechanisms involving the regulation of cell adhesion pathways and the balancing of metastasis-related gene expression, thereby suppressing extracellular matrix degradation mediated by MMPs and reducing the migratory and invasive capacities of tumor cells (<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>). Notably, as a naturally derived medicinal plant, the bioactive constituents of <italic>C. cernuum</italic> exert potent anticancer effects with acceptable <italic>in vitro</italic> biocompatibility. This advantage enables it to potentially exert a chemosensitizing effect when combined with chemotherapeutic drugs, reducing the dosage of chemical agents and alleviating the toxic side effects on normal tissues, thereby providing a novel possibility for the optimization of clinical chemotherapeutic regimens (<xref rid="b103-ol-33-1-15938" ref-type="bibr">103</xref>).</p>
<p>Despite progress achieved in anticancer research on <italic>C. cernuum</italic>, it still faces numerous academic challenges and technical bottlenecks in the transition from basic research to clinical application. These issues not only restrict the translation efficiency but also point out the direction for subsequent research (<xref rid="b104-ol-33-1-15938" ref-type="bibr">104</xref>). First, the isolation, purification and large-scale acquisition of bioactive constituents constitute the primary current technical challenge. Most core bioactive constituents in <italic>C. cernuum</italic> are present in trace amounts and some exhibit complex structures and similar polarities. Traditional isolation and purification methods are cumbersome and inefficient, making it difficult to achieve large-scale preparation of high-purity monomers. This insufficient sample availability restricts the implementation of subsequent <italic>in vivo</italic> pharmacodynamic verification, pharmacokinetic profiling and systematic preclinical safety evaluation, greatly hindering in-depth translational research (<xref rid="b105-ol-33-1-15938" ref-type="bibr">105</xref>). Second, the extreme scarcity of standardized <italic>in vivo</italic> experimental evidence is the core limitation restricting the reliability and translational value of existing conclusions (<xref rid="b106-ol-33-1-15938" ref-type="bibr">106</xref>). Most existing studies have focused on <italic>in vitro</italic> cell experiments. Although these studies have clarified the anticancer activity and partial molecular mechanisms, there are significant differences between the <italic>in vitro</italic> environment and the complex physiological and pathological conditions <italic>in vivo</italic>. Key factors such as the regulatory role of the tumor microenvironment, the influence of drug-metabolizing enzymes and the interaction of immune cells have not been fully considered (<xref rid="b107-ol-33-1-15938" ref-type="bibr">107</xref>). Currently, <italic>in vivo</italic> studies on <italic>C. cernuum</italic> remain relatively limited, lacking systematic animal model validation for different tumor types. Furthermore, pharmacokinetic profiles and long-term toxicological data of <italic>C. cernuum</italic> remain severely lacking (<xref rid="b105-ol-33-1-15938" ref-type="bibr">105</xref>). Such data are indispensable prerequisites for advancing clinical research and their scarcity greatly hinders the translational progress of this medicinal plant from basic laboratory studies to clinical application.</p>
<p>In terms of research on the mechanism of action, the existing achievements still have insufficient depth and breadth. Current research mostly focuses on the regulation of a specific signaling pathway by a single bioactive constituent. Although the roles of some key molecules have been clarified, as a multi-component complex, the overall anticancer effect of <italic>C. cernuum</italic> is more likely derived from the synergistic regulation of multiple signaling pathways by multiple constituents. Currently, the synergistic or antagonistic interactions between different types of constituents, the cross-regulatory networks among structural analogues of the same compound class, and their collective contribution to anticancer bioactivity have not been systematically elucidated (<xref rid="b108-ol-33-1-15938" ref-type="bibr">108</xref>). Furthermore, as an important factor affecting tumor initiation and progression (<xref rid="b109-ol-33-1-15938" ref-type="bibr">109</xref>), whether the bioactive constituents of <italic>C. cernuum</italic> exert their effects through pathways such as regulating the functions of cancer-associated fibroblasts and immune cells, or inhibiting tumor angiogenesis, remains under initial research. This also limits the comprehensive understanding of its anticancer mechanism. Meanwhile, numerous obstacles in the clinical translation process cannot be ignored. To date, there are no clinical research reports on <italic>C. cernuum</italic> related preparations for tumor treatment and key issues such as their safety, efficacy, optimal dosage and administration route in humans remain unclear. Since factors such as the growth environment, harvesting time and processing methods of <italic>C. cernuum</italic> all affect its chemical composition and content, the lack of unified quality control standards will make it difficult to guarantee the pharmacodynamic stability of different batches of products, which is also a common key academic issue in the development of natural drugs. In addition, as a wild medicinal plant, long-term overharvesting of <italic>C. cernuum</italic> may lead to the depletion of natural resources. Meanwhile, the immaturity of artificial cultivation technology makes it difficult to meet the demand for large-scale development, and the issue of resource sustainability also requires adequate attention (<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>).</p>
<p>To address the aforementioned issues, future anticancer research on <italic>C. cernuum</italic> should adhere to the philosophy of interdisciplinary integration (<xref rid="b110-ol-33-1-15938" ref-type="bibr">110</xref>), conducting systematic research from multiple dimensions including technological innovation, mechanism refinement, clinical translation and resource protection. In terms of the technology for the isolation and preparation of bioactive constituents, modern and efficient separation technologies should be actively introduced and separation process parameters optimized to improve the separation efficiency and purity of bioactive constituents. Meanwhile, exploring the application of biosynthesis technology, by constructing engineered strains <italic>via</italic> genetic engineering approaches, can achieve large-scale production of core bioactive constituents, fundamentally addressing the issue of insufficient raw material supply. In terms of pharmacological and toxicological research, it is necessary to strengthen the systematicness and comprehensiveness of <italic>in vivo</italic> experiments, establish orthotopic transplantation models or patient-derived xenograft models for various tumors to more realistically simulate the clinical tumor growth characteristics (<xref rid="b111-ol-33-1-15938" ref-type="bibr">111</xref>) and comprehensively evaluate the <italic>in vivo</italic> anticancer efficacy of <italic>C. cernuum</italic> extracts and bioactive monomers. Meanwhile, systematic pharmacokinetic studies should be conducted to clarify the rules of absorption, distribution, metabolism, and excretion <italic>in vivo</italic>, thereby providing a scientific basis for the design of clinical administration regimens (<xref rid="b112-ol-33-1-15938" ref-type="bibr">112</xref>). Furthermore, long-term toxicological experiments should focus on the impacts on vital organs such as the liver, kidneys and hematopoietic system to verify its safety and toxicological characteristics, so as to support its potential clinical application.</p>
<p>Tumor progression represents systemic homeostasis disruption and multi-component natural products are well-suited to modulate these intricate interconnected regulatory networks (<xref rid="b113-ol-33-1-15938" ref-type="bibr">113</xref>). In terms of mechanism-of-action research, it is essential to break through the research paradigm of single constituent and single pathway. Multi-omics technologies such as network pharmacology, transcriptomics and proteomics should be adopted to dissect the interaction network between multiple constituents of <italic>C. cernuum</italic> and multiple targets in tumor cells, thereby clarifying the synergistic regulatory mechanisms of different constituents (<xref rid="b114-ol-33-1-15938" ref-type="bibr">114</xref>). Meanwhile, it is necessary to further explore its regulatory role in the tumor microenvironment, analyze the interactions between bioactive constituents and immune cells or vascular endothelial cells and provide theoretical support for the development of novel preparations with both direct anti-tumor and immunomodulatory functions (<xref rid="b115-ol-33-1-15938" ref-type="bibr">115</xref>). In addition, the application of artificial intelligence (AI) technology in this field is particularly essential (<xref rid="b116-ol-33-1-15938" ref-type="bibr">116</xref>). AI technologies including big data mining, target prediction, molecular simulation and intelligent screening can rapidly clarify the constituents and action mechanisms of natural products, efficiently integrate multi-omics data, optimize clinical medication regimens and medicinal material quality evaluation (<xref rid="b117-ol-33-1-15938" ref-type="bibr">117</xref>). It can comprehensively promote pharmacological research, clinical transformation and resource management of medicinal plants, and accelerate and improve the research and development of natural anti-tumor drugs (<xref rid="b118-ol-33-1-15938" ref-type="bibr">118</xref>).</p>
<p>In terms of clinical translation, the scientific pathway of &#x2018;preclinical research-clinical trials&#x2019; should be followed. First, the preparation process should be optimized to develop dosage forms suitable for clinical application and improve the bioavailability of bioactive constituents. Phase I, II and III clinical trials will be sequentially conducted to clarify its safety and efficacy in cancer patients, explore its combination therapy regimens with chemotherapeutic agents, targeted drugs, or immune checkpoint inhibitors and assess its possible clinical therapeutic value. In terms of quality control and resource protection, a multi-index component-based quality evaluation system should be established and modern analytical techniques should be employed for the quantitative analysis of core bioactive components to ensure the stability and uniformity of product quality. Meanwhile, the resource investigation and protection of <italic>C. cernuum</italic> should be strengthened, a germplasm resource bank should be established and the conditions for artificial cultivation should be optimized to realize the sustainable utilization of its resources.</p>
<p>To summarize, as a traditional medicinal plant, <italic>C. cernuum</italic> possesses abundant chemical components and <italic>in vitro-</italic>observed anticancer activity, thereby providing a valuable natural resource for exploring potential novel anticancer drugs. Existing studies have initially confirmed its definite effects in inhibiting the proliferation, metastasis of various tumor cells and inducing their apoptosis. Furthermore, its multi-component and multi-target mode of action, coupled with the advantage of <italic>in vitro</italic> biocompatibility, endows it with certain research potential for further investigation. However, issues such as the difficulty in the large-scale acquisition of bioactive components, the scarcity of <italic>in vivo</italic> data, insufficient in-depth studies on its mechanisms, the lag in clinical translation and the insufficiency of resource sustainability still need to be addressed through multidisciplinary collaborative innovation. In the future, through the innovation of technical methods, the expansion of research depth, and the advancement of translational application, it is expected to clarify whether <italic>C. cernuum</italic> can progress from basic research to clinical application, thereby potentially offering a new natural drug option for tumor therapy and also offering a referable research paradigm for the modernized development of traditional medicinal plants.</p>
</sec>
<sec sec-type="conclusion">
<label>6.</label>
<title>Conclusion</title>
<p>The present study systematically summarized the traditional applications, chemical components, anticancer pharmacological effects, and action targets of <italic>C. cernuum</italic> It has been demonstrated that <italic>C. cernuum</italic> abounds in sesquiterpenoids, flavonoids, phenolic acids, and other bioactive components, among which sesquiterpenoids are the core anticancer bioactive components. Additionally, it contains diterpenoids and other auxiliary bioactive components, which collectively form the material basis for its broad-spectrum anticancer activity. Its bioactive components have been shown to exhibit significant inhibitory effects on various tumor cells, including prostate cancer, pancreatic cancer, leukemia and breast cancer. They can not only achieve multi-dimensional anticancer effects such as cell cycle arrest, apoptosis induction, autophagy activation, and metastasis inhibition by regulating key signaling pathways including the PI3K/Akt/mTOR signaling axis and Hippo signaling pathway, but some components can also synergistically enhance the efficacy of clinical drugs. Moreover, they exhibit low toxicity and side effects, thus possessing great potential for development as novel anticancer drugs or chemosensitizers.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>JXM, MQL and HMW wrote the manuscript and created the figures. JXM, QH and YL performed literature screening and critically revised the manuscript. Data authentication is not applicable. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethical approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-ol-33-1-15938"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Force</surname><given-names>LM</given-names></name><name><surname>Kocarnik</surname><given-names>JM</given-names></name><name><surname>May</surname><given-names>ML</given-names></name><name><surname>Bhangdia</surname><given-names>K</given-names></name><name><surname>Crist</surname><given-names>A</given-names></name><name><surname>Penberthy</surname><given-names>L</given-names></name><name><surname>Pritchett</surname><given-names>N</given-names></name><name><surname>Acheson</surname><given-names>A</given-names></name><name><surname>Deitesfeld</surname><given-names>L</given-names></name><name><surname>Bhoomadevi</surname><given-names>A</given-names></name><etal/></person-group><article-title>The global, regional, and national burden of cancer, 1990&#x2013;2023, with forecasts to 2050: A systematic analysis for the global burden of disease Study 2023</article-title><source>Lancet</source><volume>406</volume><fpage>1565</fpage><lpage>1586</lpage><year>2025</year><pub-id pub-id-type="doi">10.1016/S0140-6736(25)01635-6</pub-id></element-citation></ref>
<ref id="b2-ol-33-1-15938"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Cai</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Zhai</surname><given-names>D</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name></person-group><article-title>Therapeutic prospects of polysaccharides for ovarian cancer</article-title><source>Front Nutrition</source><volume>9</volume><fpage>879111</fpage><year>2022</year><pub-id pub-id-type="doi">10.3389/fnut.2022.879111</pub-id><pub-id pub-id-type="pmid">35464007</pub-id></element-citation></ref>
<ref id="b3-ol-33-1-15938"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aljabali</surname><given-names>AAA</given-names></name><name><surname>Bashatwah</surname><given-names>RM</given-names></name><name><surname>El-Tanani</surname><given-names>M</given-names></name><name><surname>Tambuwala</surname><given-names>MM</given-names></name></person-group><article-title>Natural anticancer drugs: Efficacy, safety, and future challenges</article-title><source>Curr Med Chem</source><volume>32</volume><fpage>6764</fpage><lpage>6805</lpage><year>2025</year><pub-id pub-id-type="doi">10.2174/0109298673344501250109210447</pub-id><pub-id pub-id-type="pmid">39871571</pub-id></element-citation></ref>
<ref id="b4-ol-33-1-15938"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Nan</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>R</given-names></name></person-group><article-title>A cross-national comparison of medicinal plants used by the Miao, Yi and Lisu ethnic groups in Yanbian, Chinam</article-title><year>2020</year><comment>doi: 10.21203/rs.3.rs-76207/v1</comment></element-citation></ref>
<ref id="b5-ol-33-1-15938"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group><article-title>An ethnobotanical study on the medicinal herb practices of the gelao ethnic minority in North Guizhou, China: An exploration of traditional knowledge</article-title><source>Front Pharmacol</source><volume>14</volume><fpage>1217599</fpage><year>2023</year><pub-id pub-id-type="doi">10.3389/fphar.2023.1217599</pub-id><pub-id pub-id-type="pmid">37719846</pub-id></element-citation></ref>
<ref id="b6-ol-33-1-15938"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>EY</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name></person-group><article-title>Green synthesis and biological activities of silver nanoparticles prepared by <italic>Carpesium cernuum</italic> extract</article-title><source>Arch Pharm Res</source><volume>42</volume><fpage>926</fpage><lpage>934</lpage><year>2019</year><pub-id pub-id-type="doi">10.1007/s12272-019-01152-x</pub-id><pub-id pub-id-type="pmid">30972559</pub-id></element-citation></ref>
<ref id="b7-ol-33-1-15938"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Rao</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name></person-group><article-title>Incaspitolide a extracted from <italic>Carpesium cernuum</italic> induces apoptosis <italic>in vitro</italic> via the PI3K/AKT pathway in benign prostatic hyperplasia</article-title><source>Biosci Rep</source><volume>41</volume><fpage>BSR20210477</fpage><year>2021</year><pub-id pub-id-type="doi">10.1042/BSR20210477</pub-id><pub-id pub-id-type="pmid">34100062</pub-id></element-citation></ref>
<ref id="b8-ol-33-1-15938"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borreguero-Mu&#x00F1;oz</surname><given-names>N</given-names></name><name><surname>Fletcher</surname><given-names>GC</given-names></name><name><surname>Aguilar-Aragon</surname><given-names>M</given-names></name><name><surname>Elbediwy</surname><given-names>A</given-names></name><name><surname>Vincent-Mistiaen</surname><given-names>ZI</given-names></name><name><surname>Thompson</surname><given-names>BJ</given-names></name></person-group><article-title>The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth</article-title><source>PLoS Biol</source><volume>17</volume><fpage>e3000509</fpage><year>2019</year><pub-id pub-id-type="doi">10.1371/journal.pbio.3000509</pub-id><pub-id pub-id-type="pmid">31613895</pub-id></element-citation></ref>
<ref id="b9-ol-33-1-15938"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>QX</given-names></name><name><surname>Yang</surname><given-names>YX</given-names></name><name><surname>Zhang</surname><given-names>JP</given-names></name><name><surname>Chen</surname><given-names>LP</given-names></name><name><surname>Shen</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>HL</given-names></name><name><surname>Zhang</surname><given-names>WD</given-names></name></person-group><article-title>Isolation, structure elucidation, and absolute configuration of highly oxygenated germacranolides from <italic>Carpesium cernuum</italic></article-title><source>J Nat Prod</source><volume>79</volume><fpage>2479</fpage><lpage>2486</lpage><year>2016</year><pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00315</pub-id><pub-id pub-id-type="pmid">27668963</pub-id></element-citation></ref>
<ref id="b10-ol-33-1-15938"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>R</given-names></name></person-group><article-title>Study on the chemical composition and biological activity of secondary metabolites from endophytic fungi of medicinal plant <italic>Carpesium cernuum</italic> L. and <italic>Saxifraga umbellulata</italic> Hook. f. et Thoms</article-title><publisher-name>Lanzhou Lanzhou University of Technology</publisher-name><year>2024</year></element-citation></ref>
<ref id="b11-ol-33-1-15938"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>WQ</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>TY</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group><article-title>Carpescernolides A and B, rare oxygen bridge-containing sesquiterpene lactones from <italic>Carpesium cernuum</italic></article-title><source>Tetrahedron Lett</source><volume>59</volume><fpage>4063</fpage><lpage>4066</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.tetlet.2018.09.067</pub-id></element-citation></ref>
<ref id="b12-ol-33-1-15938"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baruah</surname><given-names>R</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Thyagarajan</surname><given-names>RP</given-names></name><name><surname>Herz</surname><given-names>W</given-names></name><name><surname>Govindan</surname><given-names>SV</given-names></name><name><surname>Blount</surname><given-names>JF</given-names></name></person-group><article-title>Unusual germacranolides from <italic>Inula eupatorioides</italic></article-title><source>J Organic Chem</source><volume>45</volume><fpage>4838</fpage><lpage>4843</lpage><year>1980</year><pub-id pub-id-type="doi">10.1021/jo01312a007</pub-id></element-citation></ref>
<ref id="b13-ol-33-1-15938"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Gajendran</surname><given-names>BABU</given-names></name><name><surname>Madhu Varier</surname><given-names>K</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><name><surname>Mao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title><italic>Germacranolide sesquiterpenes</italic> from <italic>Carpesium cernuum</italic> and their anti-leukemia activity</article-title><source>Chin J Natural Med</source><volume>19</volume><fpage>528</fpage><lpage>535</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/S1875-5364(21)60052-3</pub-id><pub-id pub-id-type="pmid">34247776</pub-id></element-citation></ref>
<ref id="b14-ol-33-1-15938"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JW</given-names></name><name><surname>Tang</surname><given-names>CP</given-names></name><name><surname>Cai</surname><given-names>YY</given-names></name><name><surname>Ke</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name></person-group><article-title>Cytotoxic germacrane-type sesquiterpene lactones from the whole plant of <italic>Inula cappa</italic></article-title><source>Chin Chem Lett</source><volume>28</volume><fpage>927</fpage><lpage>930</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.cclet.2016.11.011</pub-id></element-citation></ref>
<ref id="b15-ol-33-1-15938"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x0142;eczek</surname><given-names>N</given-names></name><name><surname>Malarz</surname><given-names>J</given-names></name><name><surname>Gierlikowska</surname><given-names>B</given-names></name><name><surname>Skalniak</surname><given-names>&#x0141;</given-names></name><name><surname>Galanty</surname><given-names>A</given-names></name><name><surname>Kiss</surname><given-names>AK</given-names></name><name><surname>Stojakowska</surname><given-names>A</given-names></name></person-group><article-title>Germacranolides from <italic>Carpesium divaricatum</italic>: Some new data on cytotoxic and anti-inflammatory activity</article-title><source>Molecules</source><volume>26</volume><fpage>4644</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/molecules26154644</pub-id><pub-id pub-id-type="pmid">34361797</pub-id></element-citation></ref>
<ref id="b16-ol-33-1-15938"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>XR</given-names></name><name><surname>Zhang</surname><given-names>SD</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>JJ</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>YH</given-names></name><name><surname>Yan</surname><given-names>SK</given-names></name><name><surname>Jin</surname><given-names>HZ</given-names></name><name><surname>Zhang</surname><given-names>WD</given-names></name></person-group><article-title>Bioactive eudesmane and germacrane derivatives from <italic>Inula Wissmanniana</italic> Hand.-Mazz</article-title><source>Phytochemistry</source><volume>96</volume><fpage>214</fpage><lpage>222</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.10.006</pub-id><pub-id pub-id-type="pmid">24189347</pub-id></element-citation></ref>
<ref id="b17-ol-33-1-15938"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Si</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>QB</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name><name><surname>Zou</surname><given-names>ZM</given-names></name></person-group><article-title>New highly oxygenated germacranolides from <italic>Carpesium divaricatum</italic> and their cytotoxic activity</article-title><source>Sci Rep</source><volume>6</volume><fpage>27237</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep27237</pub-id><pub-id pub-id-type="pmid">27265755</pub-id></element-citation></ref>
<ref id="b18-ol-33-1-15938"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mossa</surname><given-names>JS</given-names></name><name><surname>El-Feraly</surname><given-names>FS</given-names></name><name><surname>Muhammad</surname><given-names>I</given-names></name><name><surname>Zaw</surname><given-names>K</given-names></name><name><surname>Mbwambo</surname><given-names>ZH</given-names></name><name><surname>Pezzuto</surname><given-names>JM</given-names></name><name><surname>Fong</surname><given-names>HHS</given-names></name></person-group><article-title>Sesquiterpene lactones and thymol esters from <italic>Vicoa pentanema</italic></article-title><source>J Nat Prod</source><volume>60</volume><fpage>550</fpage><lpage>555</lpage><year>1997</year><pub-id pub-id-type="doi">10.1021/np960506o</pub-id></element-citation></ref>
<ref id="b19-ol-33-1-15938"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Jia</surname><given-names>ZJ</given-names></name></person-group><article-title>Cytotoxic germacranolides and acyclic diterpenoides from the seeds of <italic>Carpesium triste</italic></article-title><source>J Nat Prod</source><volume>70</volume><fpage>830</fpage><lpage>834</lpage><year>2007</year><pub-id pub-id-type="doi">10.1021/np0700570</pub-id><pub-id pub-id-type="pmid">17432904</pub-id></element-citation></ref>
<ref id="b20-ol-33-1-15938"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>QX</given-names></name><name><surname>Yong</surname><given-names>W</given-names></name><name><surname>Jia</surname><given-names>JJ</given-names></name></person-group><article-title>A new eudesmanolide and a new aromatic derivative from <italic>Carpesium cernuun</italic></article-title><source>Chin Chemical Lett</source><volume>12</volume><fpage>597</fpage><year>2001</year></element-citation></ref>
<ref id="b21-ol-33-1-15938"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name></person-group><article-title>Chemical constituents of the aerial parts of <italic>Carpesium cernuun</italic></article-title><source>Journal of Lanzhou University</source><volume>38</volume><fpage>61</fpage><lpage>67</lpage><year>2002</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b22-ol-33-1-15938"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Ren</surname><given-names>FC</given-names></name><name><surname>Liu</surname><given-names>JK</given-names></name></person-group><article-title>Sesquiterpene lactones from Carpesium abrotanoides</article-title><source>Fitoterapia</source><volume>80</volume><fpage>21</fpage><lpage>24</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.fitote.2008.09.009</pub-id><pub-id pub-id-type="pmid">18948175</pub-id></element-citation></ref>
<ref id="b23-ol-33-1-15938"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>YP</given-names></name><name><surname>Jia</surname><given-names>ZJ</given-names></name></person-group><article-title>Sesquiterpene lactone glycosides, eudesmanolides, and other constituents from <italic>Carpesium macrocephalum</italic></article-title><source>Planta Med</source><volume>68</volume><fpage>626</fpage><lpage>630</lpage><year>2002</year><pub-id pub-id-type="doi">10.1055/s-2002-32899</pub-id><pub-id pub-id-type="pmid">12142997</pub-id></element-citation></ref>
<ref id="b24-ol-33-1-15938"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holub</surname><given-names>M</given-names></name><name><surname>Samek</surname><given-names>Z</given-names></name><name><surname>Toman</surname><given-names>J</given-names></name></person-group><article-title>Carabrone from <italic>Arnica foliosa</italic></article-title><source>Phytochemistry</source><volume>11</volume><fpage>2627</fpage><lpage>2628</lpage><year>1972</year><pub-id pub-id-type="doi">10.1016/S0031-9422(00)88561-1</pub-id></element-citation></ref>
<ref id="b25-ol-33-1-15938"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>JL</given-names></name></person-group><article-title>Study on supercritical CO<sub>2</sub> extraction, antioxidant and antibacterial activities of volatile oil from flower buds of Magnolia wufengensis &#x2018;Jiaohong No.1&#x2019;</article-title><publisher-name>Beijing</publisher-name><publisher-loc>Beijing Forestry University</publisher-loc><year>2020</year></element-citation></ref>
<ref id="b26-ol-33-1-15938"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WH</given-names></name><name><surname>Ma</surname><given-names>XM</given-names></name><name><surname>Wu</surname><given-names>QX</given-names></name><name><surname>Shi</surname><given-names>YP</given-names></name></person-group><article-title>Chemical-constituent diversity of <italic>Tridax procumbens</italic></article-title><source>Can J Chem</source><volume>86</volume><fpage>892</fpage><lpage>898</lpage><year>2008</year><pub-id pub-id-type="doi">10.1139/v08-097</pub-id></element-citation></ref>
<ref id="b27-ol-33-1-15938"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Chemical constituents from <italic>Carpesium cernuum</italic> and their anti-leukemia activities <italic>in vitro</italic></article-title><source>Guangxi Zhiwu</source><volume>43</volume><fpage>2139</fpage><lpage>2148</lpage><year>2023</year></element-citation></ref>
<ref id="b28-ol-33-1-15938"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>WQ</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chemical constituents in <italic>Carpesium cernuum</italic> and their cytotoxic activity</article-title><source>Natural Product Research and Development</source><volume>34</volume><fpage>383</fpage><lpage>389</lpage><year>2022</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b29-ol-33-1-15938"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>WQ</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name></person-group><article-title>Three new diterpenoids from whole herb of <italic>Carpesium cernuum</italic></article-title><source>China J Chin Materia</source><volume>48</volume><fpage>5244</fpage><lpage>5249</lpage><year>2023</year><pub-id pub-id-type="pmid">38114113</pub-id></element-citation></ref>
<ref id="b30-ol-33-1-15938"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batterham</surname><given-names>TJ</given-names></name><name><surname>Highet</surname><given-names>RJL</given-names></name></person-group><article-title>Nuclear magnetic resonance spectra of flavonoids</article-title><source>Aust Chem</source><volume>17</volume><fpage>428</fpage><lpage>439</lpage><year>1964</year><pub-id pub-id-type="doi">10.1071/CH9640428</pub-id></element-citation></ref>
<ref id="b31-ol-33-1-15938"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>PK</given-names></name><name><surname>Blunden</surname><given-names>G</given-names></name><name><surname>Jacob</surname><given-names>C</given-names></name></person-group><article-title>Antiviral significance of isoquercetin (Quercetin-3-O-Glucoside) with special reference to its anti-coronaviral potential</article-title><source>Nat Product Commun</source><volume>19</volume><fpage>1</fpage><lpage>11</lpage><year>2024</year></element-citation></ref>
<ref id="b32-ol-33-1-15938"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beninger</surname><given-names>CW</given-names></name><name><surname>Hosfield</surname><given-names>GL</given-names></name></person-group><article-title>Flavonol glycosides from Montcalm dark red kidney bean: Implications for the genetics of seed coat color in <italic>Phaseolus vulgaris</italic> L</article-title><source>J Agric Food Chem</source><volume>47</volume><fpage>4079</fpage><lpage>4082</lpage><year>1999</year><pub-id pub-id-type="doi">10.1021/jf981266g</pub-id><pub-id pub-id-type="pmid">10552769</pub-id></element-citation></ref>
<ref id="b33-ol-33-1-15938"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>QX</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Jia</surname><given-names>ZJ</given-names></name></person-group><article-title>Eudesmanolides, aromatic derivatives, and other constituents from <italic>Carpesium cernuum</italic></article-title><source>Pharmazie</source><volume>56</volume><fpage>825</fpage><lpage>827</lpage><year>2001</year><pub-id pub-id-type="pmid">11683134</pub-id></element-citation></ref>
<ref id="b34-ol-33-1-15938"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>JP</given-names></name><name><surname>Tan</surname><given-names>CH</given-names></name><name><surname>Zhu</surname><given-names>DY</given-names></name></person-group><article-title>Glycosidic constituents from <italic>Carpesium cernuum</italic> L</article-title><source>J Asian Nat Prod Res</source><volume>10</volume><fpage>565</fpage><lpage>569</lpage><year>2008</year><pub-id pub-id-type="doi">10.1080/10286020801966724</pub-id><pub-id pub-id-type="pmid">18470810</pub-id></element-citation></ref>
<ref id="b35-ol-33-1-15938"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greea</surname><given-names>MD</given-names></name><name><surname>Monaco</surname><given-names>P</given-names></name><name><surname>Previtera</surname><given-names>L</given-names></name></person-group><article-title>Stiglllasterols from <italic>Typha latifolia</italic></article-title><source>Nat Products</source><volume>53</volume><fpage>1430</fpage><lpage>1435</lpage><year>1990</year><pub-id pub-id-type="doi">10.1021/np50072a005</pub-id></element-citation></ref>
<ref id="b36-ol-33-1-15938"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meagher</surname><given-names>LP</given-names></name><name><surname>Beecher</surname><given-names>GR</given-names></name><name><surname>Flanagan</surname><given-names>VP</given-names></name><name><surname>Li</surname><given-names>BW</given-names></name></person-group><article-title>Isolation and characterization of the lignans, isolariciresinol and pinoresinol, in flaxseed meal</article-title><source>J Agric Food Chem</source><volume>47</volume><fpage>3173</fpage><lpage>3180</lpage><year>1999</year><pub-id pub-id-type="doi">10.1021/jf981359y</pub-id><pub-id pub-id-type="pmid">10552626</pub-id></element-citation></ref>
<ref id="b37-ol-33-1-15938"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyu</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>W</given-names></name></person-group><article-title>Modulation of IL-12 and IFN-&#x03B3; Secretions by Eleutheroside E, <italic>Tortoside A</italic>, and Syringaresinol from <italic>Acanthopanax Koreanum</italic> Nakai</article-title><source>Korean Soc Appl Pharmacol</source><volume>18</volume><fpage>211</fpage><lpage>218</lpage><year>2010</year></element-citation></ref>
<ref id="b38-ol-33-1-15938"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>DY</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Heo</surname><given-names>JW</given-names></name><name><surname>No</surname><given-names>MH</given-names></name><name><surname>Rhee</surname><given-names>BD</given-names></name><name><surname>Ko</surname><given-names>KS</given-names></name><name><surname>Kwak</surname><given-names>HB</given-names></name><name><surname>Han</surname><given-names>J</given-names></name></person-group><article-title>Ursolic acid in health and disease</article-title><source>Korean J Physiol Pharmacol</source><volume>22</volume><fpage>235</fpage><lpage>248</lpage><year>2018</year><pub-id pub-id-type="doi">10.4196/kjpp.2018.22.3.235</pub-id><pub-id pub-id-type="pmid">29719446</pub-id></element-citation></ref>
<ref id="b39-ol-33-1-15938"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malarz</surname><given-names>J</given-names></name><name><surname>Jantas</surname><given-names>D</given-names></name><name><surname>Jakubowska</surname><given-names>K</given-names></name><name><surname>Bugno</surname><given-names>R</given-names></name><name><surname>Kiss</surname><given-names>AK</given-names></name><name><surname>Stojakowska</surname><given-names>A</given-names></name></person-group><article-title>New Terpenoids and Polyphenolic Profile of <italic>Carpesium cernuum</italic> L. of European Origin</article-title><source>Molecules</source><volume>30</volume><fpage>2506</fpage><year>2025</year><pub-id pub-id-type="doi">10.3390/molecules30122506</pub-id><pub-id pub-id-type="pmid">40572472</pub-id></element-citation></ref>
<ref id="b40-ol-33-1-15938"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flourat</surname><given-names>AL</given-names></name><name><surname>Combes</surname><given-names>J</given-names></name><name><surname>Bailly-Maitre-Grand</surname><given-names>C</given-names></name><name><surname>Magnien</surname><given-names>K</given-names></name><name><surname>Haudrechy</surname><given-names>A</given-names></name><name><surname>Renault</surname><given-names>JH</given-names></name><name><surname>Allais</surname><given-names>F</given-names></name></person-group><article-title>Accessing p-hydroxycinnamic acids: Chemical synthesis, biomass recovery, or engineered microbial production?</article-title><source>ChemSusChem</source><volume>14</volume><fpage>118</fpage><lpage>129</lpage><year>2021</year><pub-id pub-id-type="doi">10.1002/cssc.202002141</pub-id><pub-id pub-id-type="pmid">33058548</pub-id></element-citation></ref>
<ref id="b41-ol-33-1-15938"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>RW</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name><name><surname>Wu</surname><given-names>YS</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>QT</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name></person-group><article-title>NMR assignments and single-crystal X-ray diffraction analysis of deoxyloganic acid</article-title><source>Magn Reson Chem</source><volume>43</volume><fpage>92</fpage><lpage>96</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/mrc.1502</pub-id><pub-id pub-id-type="pmid">15505818</pub-id></element-citation></ref>
<ref id="b42-ol-33-1-15938"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>LQ</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Study on the chemical constituents from the aerial parts of Blumea balsamifera DC. and their antioxidant and tyrosinase inhibitory activities</article-title><source>Natural Product Research and Development</source><volume>33</volume><fpage>1112</fpage><lpage>1120</lpage><year>2021</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b43-ol-33-1-15938"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Wermuth</surname><given-names>U</given-names></name></person-group><article-title>Indole-3-carboxylic acid</article-title><source>Acta Crystallogr</source><volume>59</volume><fpage>o1766</fpage><lpage>o1767</lpage><year>2003</year></element-citation></ref>
<ref id="b44-ol-33-1-15938"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Zong</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>MY</given-names></name><name><surname>Liu</surname><given-names>FY</given-names></name><name><surname>Meng</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><article-title>7-Hydroxycoumarin mitigates the severity of collagen-induced arthritis in rats by inhibiting proliferation and inducing apoptosis of fibroblast-like synoviocytes via suppression of Wnt/&#x03B2;-catenin signaling pathway</article-title><source>Phytomedicine</source><volume>94</volume><fpage>153841</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.phymed.2021.153841</pub-id><pub-id pub-id-type="pmid">34752968</pub-id></element-citation></ref>
<ref id="b45-ol-33-1-15938"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nghiem</surname><given-names>NP</given-names></name><name><surname>Kleff</surname><given-names>S</given-names></name><name><surname>Schwegmann</surname><given-names>S</given-names></name></person-group><article-title>Succinic acid: Technology development and commercialization</article-title><source>Fermentation</source><volume>3</volume><fpage>26</fpage><year>2017</year><pub-id pub-id-type="doi">10.3390/fermentation3020026</pub-id></element-citation></ref>
<ref id="b46-ol-33-1-15938"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondul</surname><given-names>AM</given-names></name><name><surname>Moore</surname><given-names>SC</given-names></name><name><surname>Weinstein</surname><given-names>SJ</given-names></name><name><surname>M&#x00E4;nnist&#x00F6;</surname><given-names>S</given-names></name><name><surname>Sampson</surname><given-names>JN</given-names></name><name><surname>Albanes</surname><given-names>D</given-names></name></person-group><article-title>1-Stearoylglycerol is associated with risk of prostate cancer: Results from a serum metabolomic profiling analysis</article-title><source>Metabolomics</source><volume>10</volume><fpage>1036</fpage><lpage>1041</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s11306-014-0643-0</pub-id><pub-id pub-id-type="pmid">25254003</pub-id></element-citation></ref>
<ref id="b47-ol-33-1-15938"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghaddam</surname><given-names>FM</given-names></name><name><surname>Farimani</surname><given-names>MM</given-names></name><name><surname>Seirafi</surname><given-names>M</given-names></name><name><surname>Taheri</surname><given-names>S</given-names></name><name><surname>Khavasi</surname><given-names>HR</given-names></name><name><surname>Sendker</surname><given-names>J</given-names></name><name><surname>Proksch</surname><given-names>P</given-names></name><name><surname>Wray</surname><given-names>V</given-names></name><name><surname>Edrada</surname><given-names>R</given-names></name></person-group><article-title>Sesterterpenoids and other constituents of <italic>Salvia sahendica</italic></article-title><source>Nat Prod</source><volume>73</volume><fpage>1601</fpage><lpage>1605</lpage><year>2010</year><pub-id pub-id-type="doi">10.1021/np1002516</pub-id><pub-id pub-id-type="pmid">20735065</pub-id></element-citation></ref>
<ref id="b48-ol-33-1-15938"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structural insights into a dual-substrate O-methyltransferase reveal the enzymatic mechanism of parallel paeonol biosynthesis</article-title><source>Nat Commun</source><year>2026</year><comment>doi: 10.1038/s41467-026-77639-1</comment></element-citation></ref>
<ref id="b49-ol-33-1-15938"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zanin</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>N</given-names></name></person-group><article-title>Aurantiamide acetate from <italic>Baphicacanthus cusia</italic> root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-&#x03BA;B signaling pathway in Influenza A virus-infected cells</article-title><source>J Ethnopharmacol</source><volume>199</volume><fpage>60</fpage><lpage>67</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.jep.2017.01.038</pub-id><pub-id pub-id-type="pmid">28119097</pub-id></element-citation></ref>
<ref id="b50-ol-33-1-15938"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Min</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Na</surname><given-names>M</given-names></name><name><surname>Kwon</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Bae</surname><given-names>K</given-names></name></person-group><article-title>Cytotoxic sesquiterpene lactones from <italic>Carpesium abrotanoides</italic></article-title><source>Planta Medica</source><volume>68</volume><fpage>745</fpage><lpage>747</lpage><year>2002</year><pub-id pub-id-type="doi">10.1055/s-2002-33789</pub-id><pub-id pub-id-type="pmid">12221601</pub-id></element-citation></ref>
<ref id="b51-ol-33-1-15938"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>ZJ</given-names></name></person-group><article-title>Sesquiterpene lactone glycosides from <italic>Carpesium macrocephalum</italic></article-title><source>Chin Chem Lett</source><volume>13</volume><fpage>247</fpage><lpage>248</lpage><year>2002</year></element-citation></ref>
<ref id="b52-ol-33-1-15938"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>JT</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>SX</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Synthesis and antifungal activities of carabrol ester derivatives</article-title><source>J Agric Food Chem</source><volume>60</volume><fpage>3817</fpage><lpage>3823</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/jf205123d</pub-id><pub-id pub-id-type="pmid">22443262</pub-id></element-citation></ref>
<ref id="b53-ol-33-1-15938"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x00E4;usler</surname><given-names>M</given-names></name><name><surname>Montag</surname><given-names>A</given-names></name></person-group><article-title>Isolation, identification and quantitative determination of the norisoprenoid (S)-(&#x002B;)-dehydrovomifoliol in honey</article-title><source>Z Lebensmittel-Untersuchung Forschung</source><volume>189</volume><fpage>113</fpage><lpage>115</lpage><year>1989</year><pub-id pub-id-type="doi">10.1007/BF01332942</pub-id></element-citation></ref>
<ref id="b54-ol-33-1-15938"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Si</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>QB</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>HW</given-names></name><name><surname>Jia</surname><given-names>HM</given-names></name><name><surname>Zou</surname><given-names>ZM</given-names></name></person-group><article-title>Three new highly oxygenated germacranolides from <italic>Carpesium divaricatum</italic> and their cytotoxic activity</article-title><source>Molecules</source><volume>23</volume><fpage>1078</fpage><year>2018</year><pub-id pub-id-type="doi">10.3390/molecules23051078</pub-id><pub-id pub-id-type="pmid">29751555</pub-id></element-citation></ref>
<ref id="b55-ol-33-1-15938"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>WQ</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>TY</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name></person-group><article-title>Carpescernolides A and B, rare oxygen bridge-containing sesquiterpene lactones from <italic>Carpesium cernuum</italic></article-title><source>Tetrahedron Lett</source><volume>59</volume><fpage>4063</fpage><lpage>4066</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.tetlet.2018.09.067</pub-id></element-citation></ref>
<ref id="b56-ol-33-1-15938"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LL</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>JL</given-names></name><name><surname>Shi</surname><given-names>YP</given-names></name></person-group><article-title>Diversity of Sesquiterpenoids from <italic>Carpesium cernuum</italic></article-title><source>Helvetica Chimica Acta</source><volume>93</volume><year>2010</year><comment>doi: 10.1002/hlca.200900275</comment><pub-id pub-id-type="doi">10.1002/hlca.200900275</pub-id><pub-id pub-id-type="pmid">24223428</pub-id></element-citation></ref>
<ref id="b57-ol-33-1-15938"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Jing</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>K</given-names></name><name><surname>Xing</surname><given-names>W</given-names></name><etal/></person-group><article-title>Identification of <italic>Carpesium cernuum</italic> extract as a tumor migration inhibitor based on its biological response profiling in breast cancer cells</article-title><source>Phytomedicine</source><volume>64</volume><fpage>153072</fpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.phymed.2019.153072</pub-id><pub-id pub-id-type="pmid">31480012</pub-id></element-citation></ref>
<ref id="b58-ol-33-1-15938"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>YD</given-names></name><name><surname>Babu</surname><given-names>G</given-names></name><name><surname>Krishnapriya</surname><given-names>MV</given-names></name><name><surname>Qiu</surname><given-names>JF</given-names></name><name><surname>Song</surname><given-names>JR</given-names></name><name><surname>Rao</surname><given-names>Q</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>YM</given-names></name></person-group><article-title>Germacranolide sesquiterpenes from <italic>Carpesium cernuum</italic> and their anti-leukemia activity</article-title><source>Chin J Nat Med</source><volume>19</volume><fpage>528</fpage><lpage>535</lpage><year>2021</year><pub-id pub-id-type="pmid">34247776</pub-id></element-citation></ref>
<ref id="b59-ol-33-1-15938"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>M</given-names></name></person-group><article-title>Sesquiterpene lactones from <italic>Carpesium divaricatum</italic></article-title><source>Phytochemistry</source><volume>29</volume><fpage>547</fpage><lpage>550</lpage><year>1990</year><pub-id pub-id-type="doi">10.1016/0031-9422(90)85115-V</pub-id></element-citation></ref>
<ref id="b60-ol-33-1-15938"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>WH</given-names></name><name><surname>Meepagala</surname><given-names>KM</given-names></name><name><surname>Fronczek</surname><given-names>FR</given-names></name><name><surname>Cook</surname><given-names>DD</given-names></name><name><surname>Wedge</surname><given-names>DE</given-names></name><name><surname>Duke</surname><given-names>SO</given-names></name></person-group><article-title>Bioassay-guided isolation and structure elucidation of fungicidal and herbicidal compounds from <italic>Ambrosia salsola</italic> (Asteraceae)</article-title><source>Molecules</source><volume>24</volume><fpage>835</fpage><year>2019</year><pub-id pub-id-type="doi">10.3390/molecules24050835</pub-id><pub-id pub-id-type="pmid">30813648</pub-id></element-citation></ref>
<ref id="b61-ol-33-1-15938"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguiar</surname><given-names>JC</given-names></name><name><surname>Santiago</surname><given-names>GM</given-names></name><name><surname>Lavor</surname><given-names>PL</given-names></name><name><surname>Veras</surname><given-names>HN</given-names></name><name><surname>Ferreira</surname><given-names>YS</given-names></name><name><surname>Lima</surname><given-names>MA</given-names></name><name><surname>Arriaga</surname><given-names>AM</given-names></name><name><surname>Lemos</surname><given-names>TL</given-names></name><name><surname>Lima</surname><given-names>JQ</given-names></name><name><surname>de Jesus</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Chemical constituents and larvicidal activity of <italic>Hymenaea courbaril</italic> fruit peel</article-title><source>Nat Prod Commun</source><volume>5</volume><fpage>1977</fpage><lpage>1980</lpage><year>2010</year><pub-id pub-id-type="pmid">21299135</pub-id></element-citation></ref>
<ref id="b62-ol-33-1-15938"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>YM</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>QW</given-names></name></person-group><article-title>Chemical constituents of <italic>Inula helenium</italic></article-title><source>Chem Nat Comp</source><volume>49</volume><fpage>1121</fpage><lpage>1122</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10600-014-0835-x</pub-id></element-citation></ref>
<ref id="b63-ol-33-1-15938"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulyyasov</surname><given-names>AT</given-names></name><name><surname>Seitembetov</surname><given-names>TS</given-names></name><name><surname>Turdybekov</surname><given-names>KM</given-names></name><name><surname>Adekenov</surname><given-names>SM</given-names></name></person-group><article-title>Epoxidation of alantolactone and isoalantolactone</article-title><source>Chem Nat Comp</source><volume>32</volume><fpage>869</fpage><lpage>872</lpage><year>1996</year><pub-id pub-id-type="doi">10.1007/BF01374017</pub-id></element-citation></ref>
<ref id="b64-ol-33-1-15938"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PA</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>WW</given-names></name><etal/></person-group><article-title>Study on chemical constituents from Carpesium abrotanoides</article-title><source>Zhong Yao Cai</source><volume>37</volume><fpage>2213</fpage><lpage>2215</lpage><year>2014</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">26080506</pub-id></element-citation></ref>
<ref id="b65-ol-33-1-15938"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XW</given-names></name><name><surname>Weng</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Pang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>HF</given-names></name><name><surname>Hu</surname><given-names>JF</given-names></name></person-group><article-title>Antiproliferative and apoptotic sesquiterpene lactones from <italic>Carpesium faberi</italic></article-title><source>Bioorg Med Chem Lett</source><volume>21</volume><fpage>366</fpage><lpage>372</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.10.138</pub-id><pub-id pub-id-type="pmid">21109433</pub-id></element-citation></ref>
<ref id="b66-ol-33-1-15938"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhavale</surname><given-names>DD</given-names></name><name><surname>Mali</surname><given-names>VP</given-names></name><name><surname>Sudrik</surname><given-names>SG</given-names></name><name><surname>Sonawane</surname><given-names>HR</given-names></name></person-group><article-title>Media controlled photo-Favorskii type rearrangement of &#x03B1;-chloro acetophenones: Synthesis of phenylacetic acids</article-title><source>Tetrahedron</source><volume>53</volume><fpage>16789</fpage><lpage>16794</lpage><year>1997</year><pub-id pub-id-type="doi">10.1016/S0040-4020(97)10081-3</pub-id></element-citation></ref>
<ref id="b67-ol-33-1-15938"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>XR</given-names></name><name><surname>Yan</surname><given-names>SK</given-names></name><name><surname>Jin</surname><given-names>HZ</given-names></name><name><surname>Zhang</surname><given-names>WD</given-names></name></person-group><article-title>Chemical constituents of <italic>Inula falconeri</italic></article-title><source>Chem Nat Compd</source><volume>50</volume><fpage>342</fpage><lpage>343</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10600-014-0947-3</pub-id></element-citation></ref>
<ref id="b68-ol-33-1-15938"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stojakowska</surname><given-names>A</given-names></name><name><surname>K&#x0142;dzia</surname><given-names>B</given-names></name><name><surname>Kisiel</surname><given-names>W</given-names></name></person-group><article-title>Antimicrobial activity of 10-isobutyryloxy-8,9-epoxythymol isobutyrate</article-title><source>Fitoterapia</source><volume>76</volume><fpage>687</fpage><lpage>690</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.fitote.2005.05.003</pub-id><pub-id pub-id-type="pmid">16242268</pub-id></element-citation></ref>
<ref id="b69-ol-33-1-15938"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>But</surname><given-names>PPH</given-names></name><name><surname>Ooi</surname><given-names>VEC</given-names></name></person-group><article-title>Antiviral activity and mode of action of caffeoylquinic acids from <italic>Schefflera heptaphylla</italic> (L.) Frodin</article-title><source>Antiviral Res</source><volume>68</volume><fpage>1</fpage><lpage>9</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.antiviral.2005.06.004</pub-id><pub-id pub-id-type="pmid">16140400</pub-id></element-citation></ref>
<ref id="b70-ol-33-1-15938"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>Rapid determination of caffeoylquinic acid derivatives in <italic>Cynara scolymus</italic> L. by ultra-fast liquid chromatography/tandem mass spectrometry based on a fused core C18 column</article-title><source>J Sep Sci</source><volume>33</volume><fpage>3152</fpage><lpage>3158</lpage><year>2010</year><pub-id pub-id-type="doi">10.1002/jssc.201000397</pub-id><pub-id pub-id-type="pmid">20824661</pub-id></element-citation></ref>
<ref id="b71-ol-33-1-15938"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Park</surname><given-names>RY</given-names></name><name><surname>Jeon</surname><given-names>HJ</given-names></name><name><surname>Kwon</surname><given-names>YS</given-names></name><name><surname>Chun</surname><given-names>W</given-names></name></person-group><article-title>Neuroprotective effects of 3,5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells</article-title><source>Phytother Res</source><volume>19</volume><fpage>243</fpage><lpage>245</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/ptr.1652</pub-id><pub-id pub-id-type="pmid">15934031</pub-id></element-citation></ref>
<ref id="b72-ol-33-1-15938"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamae</surname><given-names>Y</given-names></name><name><surname>Kurisu</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>K</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Isoda</surname><given-names>H</given-names></name><name><surname>Irie</surname><given-names>K</given-names></name><name><surname>Shigemori</surname><given-names>H</given-names></name></person-group><article-title>Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid &#x03B2;-protein</article-title><source>Bioorg Med Chem</source><volume>20</volume><fpage>5844</fpage><lpage>5849</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bmc.2012.08.001</pub-id><pub-id pub-id-type="pmid">22921742</pub-id></element-citation></ref>
<ref id="b73-ol-33-1-15938"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakrim</surname><given-names>S</given-names></name><name><surname>Benkhaira</surname><given-names>N</given-names></name><name><surname>Bourais</surname><given-names>I</given-names></name><name><surname>Benali</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>LH</given-names></name><name><surname>El Omari</surname><given-names>N</given-names></name><name><surname>Sheikh</surname><given-names>RA</given-names></name><name><surname>Goh</surname><given-names>KW</given-names></name><name><surname>Ming</surname><given-names>LC</given-names></name><name><surname>Bouyahya</surname><given-names>A</given-names></name></person-group><article-title>Health benefits and pharmacological properties of stigmasterol</article-title><source>Antioxidants</source><volume>11</volume><fpage>1912</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/antiox11101912</pub-id><pub-id pub-id-type="pmid">36290632</pub-id></element-citation></ref>
<ref id="b74-ol-33-1-15938"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>AR</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Jayaprakash</surname><given-names>KS</given-names></name><name><surname>Gunasekaran</surname><given-names>S</given-names></name><name><surname>Kumaresan</surname><given-names>A</given-names></name><name><surname>Devanathan</surname><given-names>J</given-names></name><name><surname>Selvam</surname><given-names>KA</given-names></name><name><surname>Ramadass</surname><given-names>L</given-names></name><name><surname>Mani</surname><given-names>M</given-names></name><name><surname>Rajkumar</surname><given-names>P</given-names></name></person-group><article-title>Multi-spectroscopic (FT-IR, FT-Raman, <sup>1</sup>H NMR and <sup>13</sup>C NMR) investigations on syringaldehyde</article-title><source>J Mol Structure</source><volume>1229</volume><fpage>129490</fpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.molstruc.2020.129490</pub-id></element-citation></ref>
<ref id="b75-ol-33-1-15938"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>BD</given-names></name><name><surname>Barreto</surname><given-names>DW</given-names></name><name><surname>Coelho</surname><given-names>MA</given-names></name></person-group><article-title>Technological Aspects of &#x03B2;-carotene production</article-title><source>Food Bioprocess Technol</source><volume>4</volume><fpage>693</fpage><lpage>701</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/s11947-011-0545-3</pub-id></element-citation></ref>
<ref id="b76-ol-33-1-15938"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><etal/></person-group><article-title>Effects of water extract from <italic>Carpesium cernuum</italic> on proliferation, metastasis and invasion of prostate cancer PC3 cells</article-title><source>China Pharmacy</source><volume>32</volume><fpage>1830</fpage><lpage>1836</lpage><year>2021</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b77-ol-33-1-15938"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>YD</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>JY</given-names></name><name><surname>Sang</surname><given-names>CY</given-names></name><name><surname>Yang</surname><given-names>JL</given-names></name></person-group><article-title>A carabrane-type <italic>Sesquiterpenolide carabrone</italic> from <italic>Carpesium cernuum</italic> inhibits SW1990 pancreatic cancer cells by inducing ferroptosis</article-title><source>Molecules</source><volume>27</volume><fpage>5841</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/molecules27185841</pub-id><pub-id pub-id-type="pmid">36144577</pub-id></element-citation></ref>
<ref id="b78-ol-33-1-15938"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Jia</surname><given-names>YF</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name></person-group><article-title>Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine</article-title><source>Oncol Lett</source><volume>18</volume><fpage>3065</fpage><lpage>3071</lpage><year>2019</year><pub-id pub-id-type="pmid">31452783</pub-id></element-citation></ref>
<ref id="b79-ol-33-1-15938"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G</given-names></name></person-group><article-title>Nab-Paclitaxel for the treatment of pancreatic cancer</article-title><source>Cancer Manag Res</source><volume>9</volume><fpage>85</fpage><lpage>96</lpage><year>2017</year><pub-id pub-id-type="doi">10.2147/CMAR.S127840</pub-id><pub-id pub-id-type="pmid">28356771</pub-id></element-citation></ref>
<ref id="b80-ol-33-1-15938"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>RL</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Sheng</surname><given-names>MH</given-names></name><name><surname>Han</surname><given-names>GC</given-names></name><name><surname>Sun</surname><given-names>DQ</given-names></name></person-group><article-title>Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K/AKT signaling pathway</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><volume>397</volume><fpage>8129</fpage><lpage>8143</lpage><year>2024</year><pub-id pub-id-type="doi">10.1007/s00210-024-03162-z</pub-id><pub-id pub-id-type="pmid">38789637</pub-id></element-citation></ref>
<ref id="b81-ol-33-1-15938"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>TMJ-105, an extract of <italic>Carpesium cernuum</italic>, induced G2/M phase arrest and apoptosis via the JAK2/STAT3 axis and MAPKs signaling pathway in leukemia HEL cells</article-title><source>Heliyon</source><volume>10</volume><fpage>e34115</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e34115</pub-id><pub-id pub-id-type="pmid">39108922</pub-id></element-citation></ref>
<ref id="b82-ol-33-1-15938"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group><article-title>Davanone terpenoid inhibits cisplatin-resistant acute myeloid leukemia cancer cell growth by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signalling pathway</article-title><source>J BUON</source><volume>25</volume><fpage>1607</fpage><lpage>1613</lpage><year>2020</year><pub-id pub-id-type="pmid">32862611</pub-id></element-citation></ref>
<ref id="b83-ol-33-1-15938"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ar&#x00E9;valo</surname><given-names>CM</given-names></name><name><surname>Cruz-Rodriguez</surname><given-names>N</given-names></name><name><surname>Quijano</surname><given-names>S</given-names></name><name><surname>Fiorentino</surname><given-names>S</given-names></name></person-group><article-title>Plant-derived extracts and metabolic modulation in leukemia: A promising approach to overcome treatment resistance</article-title><source>Front Mol Biosci</source><volume>10</volume><fpage>1229760</fpage><year>2023</year><pub-id pub-id-type="doi">10.3389/fmolb.2023.1229760</pub-id><pub-id pub-id-type="pmid">37520325</pub-id></element-citation></ref>
<ref id="b84-ol-33-1-15938"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>H</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Tanwar</surname><given-names>P</given-names></name><name><surname>Upadhyay</surname><given-names>TK</given-names></name><name><surname>Khan</surname><given-names>F</given-names></name><name><surname>Pandey</surname><given-names>P</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Moon</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia</article-title><source>Biomed Pharmacother</source><volume>160</volume><fpage>114351</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114351</pub-id><pub-id pub-id-type="pmid">36736284</pub-id></element-citation></ref>
<ref id="b85-ol-33-1-15938"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voon</surname><given-names>KWK</given-names></name><name><surname>Gazali</surname><given-names>AM</given-names></name><name><surname>Zamri</surname><given-names>N</given-names></name><name><surname>Rullah</surname><given-names>K</given-names></name><name><surname>Aluwi</surname><given-names>MFFM</given-names></name></person-group><article-title>A mini-review on the insight into the effect of natural and synthetic &#x03B1;, &#x03B2;-unsaturated carbonyl-containing compounds on PI3K/AKT/mTOR signaling pathways to treat breast cancer</article-title><source>J Computat Biophys Chem</source><volume>21</volume><fpage>611</fpage><lpage>627</lpage><year>2022</year><pub-id pub-id-type="doi">10.1142/S2737416522300024</pub-id></element-citation></ref>
<ref id="b86-ol-33-1-15938"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YS</given-names></name><name><surname>Mao</surname><given-names>JX</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>HW</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name></person-group><article-title>Antiprostate cancer activity of ineupatolide isolated from <italic>Carpesium cernuum</italic> L</article-title><source>Biomed Res Int</source><volume>2021</volume><fpage>5515961</fpage><year>2021</year><pub-id pub-id-type="doi">10.1155/2021/5515961</pub-id><pub-id pub-id-type="pmid">33996996</pub-id></element-citation></ref>
<ref id="b87-ol-33-1-15938"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badoiu</surname><given-names>SC</given-names></name><name><surname>Greabu</surname><given-names>M</given-names></name><name><surname>Miricescu</surname><given-names>D</given-names></name><name><surname>Stanescu-Spinu</surname><suffix>II</suffix></name><name><surname>Ilinca</surname><given-names>R</given-names></name><name><surname>Balan</surname><given-names>DG</given-names></name><name><surname>Balcangiu-Stroescu</surname><given-names>AE</given-names></name><name><surname>Mihai</surname><given-names>DA</given-names></name><name><surname>Vacaroiu</surname><given-names>IA</given-names></name><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Jinga</surname><given-names>V</given-names></name></person-group><article-title>PI3K/AKT/mTOR dysregulation and reprogramming metabolic pathways in renal cancer: Crosstalk with the VHL/HIF axis</article-title><source>Int J Mol Sci</source><volume>24</volume><fpage>8391</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/ijms24098391</pub-id><pub-id pub-id-type="pmid">37176098</pub-id></element-citation></ref>
<ref id="b88-ol-33-1-15938"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name></person-group><article-title>TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression</article-title><source>Cell Death Dis</source><volume>12</volume><fpage>642</fpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41419-021-03930-2</pub-id><pub-id pub-id-type="pmid">34162834</pub-id></element-citation></ref>
<ref id="b89-ol-33-1-15938"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><etal/></person-group><article-title>DT-13 inhibits proliferation and metastasis of human prostate cancer cells through blocking PI3K/Akt pathway</article-title><source>Front Pharmacol</source><volume>9</volume><fpage>1450</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fphar.2018.01450</pub-id><pub-id pub-id-type="pmid">30581390</pub-id></element-citation></ref>
<ref id="b90-ol-33-1-15938"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bala</surname><given-names>R</given-names></name><name><surname>Madaan</surname><given-names>R</given-names></name><name><surname>Bedi</surname><given-names>O</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Taneja</surname><given-names>A</given-names></name><name><surname>Dwivedi</surname><given-names>R</given-names></name><name><surname>Figueroa-Gonz&#x00E1;lez</surname><given-names>G</given-names></name><name><surname>Reyes-Hern&#x00E1;ndez</surname><given-names>OD</given-names></name><name><surname>Quintas-Granados</surname><given-names>LI</given-names></name><name><surname>Cort&#x00E9;s</surname><given-names>H</given-names></name><etal/></person-group><article-title>Targeting the Hippo/YAP pathway: A promising approach for cancer therapy and beyond</article-title><source>MedComm (2020)</source><volume>6</volume><fpage>e70338</fpage><year>2025</year><pub-id pub-id-type="doi">10.1002/mco2.70338</pub-id><pub-id pub-id-type="pmid">40895190</pub-id></element-citation></ref>
<ref id="b91-ol-33-1-15938"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name></person-group><article-title>The hippo signaling pathway in cancer: A cell cycle perspective</article-title><source>Cancers</source><volume>13</volume><fpage>6214</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/cancers13246214</pub-id><pub-id pub-id-type="pmid">34944834</pub-id></element-citation></ref>
<ref id="b92-ol-33-1-15938"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>M</given-names></name><name><surname>Bierie</surname><given-names>B</given-names></name><name><surname>Roy-Burman</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Wills</surname><given-names>M</given-names></name><name><surname>Matusik</surname><given-names>RJ</given-names></name></person-group><article-title>Activation of beta-catenin in mouse prostate causes HGPIN and continuous prostate growth after castration</article-title><source>Prostate</source><volume>69</volume><fpage>249</fpage><lpage>262</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/pros.20877</pub-id><pub-id pub-id-type="pmid">18991257</pub-id></element-citation></ref>
<ref id="b93-ol-33-1-15938"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loon</surname><given-names>K</given-names></name><name><surname>Huijbers</surname><given-names>EJM</given-names></name><name><surname>Griffioen</surname><given-names>AW</given-names></name></person-group><article-title>Secreted frizzled-related protein 2: A key player in noncanonical Wnt signaling and tumor angiogenesis</article-title><source>Cancer Metastasis Rev</source><volume>40</volume><fpage>191</fpage><lpage>203</lpage><year>2021</year><pub-id pub-id-type="doi">10.1007/s10555-020-09941-3</pub-id><pub-id pub-id-type="pmid">33140138</pub-id></element-citation></ref>
<ref id="b94-ol-33-1-15938"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Pan</surname><given-names>E</given-names></name><name><surname>Elliott</surname><given-names>A</given-names></name><name><surname>Beltran</surname><given-names>H</given-names></name><name><surname>Panian</surname><given-names>J</given-names></name><name><surname>Jamieson</surname><given-names>C</given-names></name><name><surname>Bagrodia</surname><given-names>A</given-names></name><name><surname>Rose</surname><given-names>B</given-names></name><name><surname>Herchenhorn</surname><given-names>D</given-names></name><name><surname>Heath</surname><given-names>E</given-names></name><etal/></person-group><article-title>Characterization of Wnt signaling pathway aberrations in metastatic prostate cancer</article-title><source>Mol Cancer Res</source><volume>22</volume><fpage>920</fpage><lpage>931</lpage><year>2024</year><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-24-0395</pub-id><pub-id pub-id-type="pmid">38912907</pub-id></element-citation></ref>
<ref id="b95-ol-33-1-15938"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>JF</given-names></name><name><surname>Yang</surname><given-names>CJ</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>ZG</given-names></name><name><surname>Yao</surname><given-names>MC</given-names></name></person-group><article-title><italic>Sanguisorba officinalis</italic> L synergistically enhanced 5-fluorouracil cytotoxicity in colorectal cancer cells by promoting a reactive oxygen species-mediated, mitochondria-caspase-dependent apoptotic pathway</article-title><source>Sci Rep</source><volume>6</volume><fpage>34245</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep34245</pub-id><pub-id pub-id-type="pmid">27671231</pub-id></element-citation></ref>
<ref id="b96-ol-33-1-15938"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian-Liang Huang</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Tsambaa</surname><given-names>B</given-names></name><name><surname>Mandakh</surname><given-names>U</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Mei</surname><given-names>W</given-names></name><etal/></person-group><article-title>Ethnobotanical study of traditional medicinal plants used by the Miao people in Hainan, China</article-title><source>J Ethnobiol Ethnomed</source><volume>21</volume><fpage>43</fpage><year>2025</year><pub-id pub-id-type="doi">10.1186/s13002-025-00795-z</pub-id><pub-id pub-id-type="pmid">40524191</pub-id></element-citation></ref>
<ref id="b97-ol-33-1-15938"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title><source>J Nat Prod</source><volume>83</volume><fpage>770</fpage><lpage>803</lpage><year>2020</year><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref>
<ref id="b98-ol-33-1-15938"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plana</surname><given-names>D</given-names></name><name><surname>Palmer</surname><given-names>AC</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name></person-group><article-title>Independent drug action in combination therapy: Implications for precision oncology</article-title><source>Cancer Discov</source><volume>12</volume><fpage>606</fpage><lpage>624</lpage><year>2022</year><pub-id pub-id-type="doi">10.1158/2159-8290.CD-21-0212</pub-id><pub-id pub-id-type="pmid">34983746</pub-id></element-citation></ref>
<ref id="b99-ol-33-1-15938"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Slominski</surname><given-names>RM</given-names></name><name><surname>Pyza</surname><given-names>E</given-names></name><name><surname>Kleszczynski</surname><given-names>K</given-names></name><name><surname>Tuckey</surname><given-names>RC</given-names></name><name><surname>Reiter</surname><given-names>RJ</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Slominski</surname><given-names>AT</given-names></name></person-group><article-title>Evolutionary formation of melatonin and vitamin D in early life forms: Insects take centre stage</article-title><source>Biol Rev Camb Philos Soc</source><volume>99</volume><fpage>1772</fpage><lpage>1790</lpage><year>2024</year><pub-id pub-id-type="doi">10.1111/brv.13091</pub-id><pub-id pub-id-type="pmid">38686544</pub-id></element-citation></ref>
<ref id="b100-ol-33-1-15938"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name></person-group><article-title>Incaspitolide A isolated from <italic>Carpesium cernuum</italic> L. inhibits the growth of prostate cancer cells and induces apoptosis via regulation of the PI3K/Akt/xIAP pathway</article-title><source>Oncol Lett</source><volume>21</volume><fpage>477</fpage><year>2021</year><pub-id pub-id-type="doi">10.3892/ol.2021.12738</pub-id><pub-id pub-id-type="pmid">33968193</pub-id></element-citation></ref>
<ref id="b101-ol-33-1-15938"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>P</given-names></name><name><surname>Duan</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>ZS</given-names></name></person-group><article-title>Natural products: A promising therapeutics for targeting tumor angiogenesis</article-title><source>Front Oncol</source><volume>11</volume><fpage>772915</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fonc.2021.772915</pub-id><pub-id pub-id-type="pmid">34746014</pub-id></element-citation></ref>
<ref id="b102-ol-33-1-15938"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Day</surname><given-names>GS</given-names></name><name><surname>Zhou</surname><given-names>HC</given-names></name></person-group><article-title>The chemistry of multi-component and hierarchical framework compounds</article-title><source>Chem Soc Rev</source><volume>48</volume><fpage>4823</fpage><lpage>4853</lpage><year>2019</year><pub-id pub-id-type="doi">10.1039/C9CS00250B</pub-id><pub-id pub-id-type="pmid">31359020</pub-id></element-citation></ref>
<ref id="b103-ol-33-1-15938"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>SK</given-names></name><name><surname>Bae</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name></person-group><article-title>Sesquiterpene alcohol cedrol chemosensitizes human cancer cells and suppresses cell proliferation by destabilizing plasma membrane lipid rafts</article-title><source>Front Cell Dev Biol</source><volume>8</volume><fpage>571676</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fcell.2020.571676</pub-id><pub-id pub-id-type="pmid">33585438</pub-id></element-citation></ref>
<ref id="b104-ol-33-1-15938"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvin</surname><given-names>N</given-names></name><name><surname>Aslam</surname><given-names>M</given-names></name><name><surname>Joo</surname><given-names>SW</given-names></name><name><surname>Mandal</surname><given-names>TK</given-names></name></person-group><article-title>Nano-phytomedicine: Harnessing plant-derived phytochemicals in nanocarriers for targeted human health applications</article-title><source>Molecules</source><volume>30</volume><fpage>3177</fpage><year>2025</year><pub-id pub-id-type="doi">10.3390/molecules30153177</pub-id><pub-id pub-id-type="pmid">40807355</pub-id></element-citation></ref>
<ref id="b105-ol-33-1-15938"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Ahmad</surname><given-names>J</given-names></name><name><surname>Ahamad</surname><given-names>J</given-names></name><name><surname>Kundu</surname><given-names>S</given-names></name><name><surname>Goel</surname><given-names>A</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name></person-group><article-title>Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope</article-title><source>Phytother Res</source><volume>37</volume><fpage>5159</fpage><lpage>5192</lpage><year>2023</year><pub-id pub-id-type="doi">10.1002/ptr.7975</pub-id><pub-id pub-id-type="pmid">37668281</pub-id></element-citation></ref>
<ref id="b106-ol-33-1-15938"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casta&#x00F1;eda</surname><given-names>AM</given-names></name><name><surname>Mel&#x00E9;ndez</surname><given-names>CM</given-names></name><name><surname>Uribe</surname><given-names>D</given-names></name><name><surname>Pedroza-D&#x00ED;az</surname><given-names>J</given-names></name></person-group><article-title>Synergistic effects of natural compounds and conventional chemotherapeutic agents: Recent insights for the development of cancer treatment strategies</article-title><source>Heliyon</source><volume>8</volume><fpage>e09519</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.heliyon.2022.e09519</pub-id><pub-id pub-id-type="pmid">35669542</pub-id></element-citation></ref>
<ref id="b107-ol-33-1-15938"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reytor-Gonz&#x00E1;lez</surname><given-names>C</given-names></name><name><surname>Jim&#x00E9;nez-Flores</surname><given-names>E</given-names></name><name><surname>Gonz&#x00E1;lez</surname><given-names>N</given-names></name><name><surname>Simancas-Racines</surname><given-names>D</given-names></name></person-group><article-title>Redefining chemoresistance: Natural bioactives as molecular modulators at the cancer-tumor microenvironment interface</article-title><source>Int J Mol Sci</source><volume>26</volume><fpage>8037</fpage><year>2025</year><pub-id pub-id-type="doi">10.3390/ijms26168037</pub-id><pub-id pub-id-type="pmid">40869364</pub-id></element-citation></ref>
<ref id="b108-ol-33-1-15938"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>F</given-names></name><name><surname>Shao</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>ZS</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xue</surname><given-names>G</given-names></name></person-group><article-title>Natural products: Promising therapeutics for targeting regulatory immune cells in the tumor microenvironment</article-title><source>Front Pharmacol</source><volume>15</volume><fpage>1481850</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fphar.2024.1481850</pub-id><pub-id pub-id-type="pmid">39605905</pub-id></element-citation></ref>
<ref id="b109-ol-33-1-15938"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neophytou</surname><given-names>CM</given-names></name><name><surname>Panagi</surname><given-names>M</given-names></name><name><surname>Stylianopoulos</surname><given-names>T</given-names></name><name><surname>Papageorgis</surname><given-names>P</given-names></name></person-group><article-title>The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities</article-title><source>Cancers</source><volume>13</volume><fpage>2053</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/cancers13092053</pub-id><pub-id pub-id-type="pmid">33922795</pub-id></element-citation></ref>
<ref id="b110-ol-33-1-15938"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Rajan</surname><given-names>R</given-names></name><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Hazra</surname><given-names>S</given-names></name></person-group><article-title>India&#x0027;s trailblazing path: A decade of progress in Traditional medicine and advancing the WHO traditional medicine strategy (2014&#x2013;2023)</article-title><source>Int J Ayurveda Res</source><volume>6</volume><fpage>82</fpage><lpage>88</lpage><year>2025</year><pub-id pub-id-type="doi">10.4103/ijar.ijar_136_25</pub-id></element-citation></ref>
<ref id="b111-ol-33-1-15938"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><article-title>Prospects and challenges of ovarian cancer organoids in chemotherapy research</article-title><source>Oncol Lett</source><volume>29</volume><fpage>198</fpage><year>2025</year><pub-id pub-id-type="doi">10.3892/ol.2025.14944</pub-id><pub-id pub-id-type="pmid">40052067</pub-id></element-citation></ref>
<ref id="b112-ol-33-1-15938"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Pharmacokinetics of honokiol in <italic>Trachinotus ovatus</italic> following administration of Honokiol monomer and Magnolia officinalis extracts</article-title><source>Aquaculture</source><volume>604</volume><fpage>742438</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.aquaculture.2025.742438</pub-id></element-citation></ref>
<ref id="b113-ol-33-1-15938"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name></person-group><article-title>Synergistic natural products in anti-ageing: Mechanistic insights, experimental evidence, and translational perspectives</article-title><source>Food Res Suppl</source><volume>1</volume><fpage>10004</fpage><year>2026</year></element-citation></ref>
<ref id="b114-ol-33-1-15938"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sheng</surname><given-names>J</given-names></name></person-group><article-title>Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma</article-title><source>Front Pharmacol</source><volume>15</volume><fpage>1374988</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fphar.2024.1374988</pub-id><pub-id pub-id-type="pmid">38560356</pub-id></element-citation></ref>
<ref id="b115-ol-33-1-15938"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slominski</surname><given-names>RM</given-names></name><name><surname>Raman</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Slominski</surname><given-names>AT</given-names></name></person-group><article-title>How cancer hijacks the body&#x0027;s homeostasis through the neuroendocrine system</article-title><source>Trends Neurosci</source><volume>46</volume><fpage>263</fpage><lpage>275</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.tins.2023.01.003</pub-id><pub-id pub-id-type="pmid">36803800</pub-id></element-citation></ref>
<ref id="b116-ol-33-1-15938"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahrawat</surname><given-names>TR</given-names></name><name><surname>Notra</surname><given-names>A</given-names></name></person-group><article-title>Identification of critical genes associated with intrahepatic cholangiocarcinoma: Weighted gene co-expression network analysis</article-title><source>Medinformatics</source><volume>2</volume><fpage>299</fpage><lpage>308</lpage><year>2025</year><pub-id pub-id-type="doi">10.47852/bonviewMEDIN52024009</pub-id></element-citation></ref>
<ref id="b117-ol-33-1-15938"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name></person-group><article-title>Capturing hallmarks of cancer through the lens of artificial intelligence</article-title><source>Intell Oncol</source><volume>2</volume><fpage>100052</fpage><year>2026</year><pub-id pub-id-type="doi">10.1016/j.intonc.2026.100052</pub-id></element-citation></ref>
<ref id="b118-ol-33-1-15938"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>E</given-names></name><name><surname>Ebrahimi</surname><given-names>M</given-names></name><name><surname>Bahramian</surname><given-names>E</given-names></name></person-group><article-title>Integrating multi-omic liquid biopsies and artificial intelligence: The next frontier in early cancer detection</article-title><source>Intell Oncol</source><volume>2</volume><fpage>100034</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.intonc.2025.12.002</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-ol-33-1-15938" position="float">
<label>Figure 1.</label>
<caption><p>Sesquiterpenes compounds from <italic>Carpesium cernuum</italic> L. (1&#x2013;30); see <xref rid="tI-ol-33-1-15938" ref-type="table">Table I</xref> for key.</p></caption>
<alt-text>Sesquiterpenes compounds from Carpesium cernuum L. (1&#x2013;30); see Table I for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g00.tiff"/>
</fig>
<fig id="f2-ol-33-1-15938" position="float">
<label>Figure 2.</label>
<caption><p>Sesquiterpenes compounds from <italic>Carpesium cernuum</italic> L. (31&#x2013;60); see <xref rid="tI-ol-33-1-15938" ref-type="table">Table I</xref> for key.</p></caption>
<alt-text>Sesquiterpenes compounds from Carpesium cernuum L. (31&#x2013;60); see Table I for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g01.tiff"/>
</fig>
<fig id="f3-ol-33-1-15938" position="float">
<label>Figure 3.</label>
<caption><p>Diterpenoid compounds from <italic>Carpesium cernuum</italic> L. (61&#x2013;69); see <xref rid="tII-ol-33-1-15938" ref-type="table">Table II</xref> for key.</p></caption>
<alt-text>Diterpenoid compounds from Carpesium cernuum L. (61&#x2013;69); see Table II for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g02.tiff"/>
</fig>
<fig id="f4-ol-33-1-15938" position="float">
<label>Figure 4.</label>
<caption><p>Flavonoid compounds from <italic>Carpesium cernuum</italic> L. (70&#x2013;72); see <xref rid="tIII-ol-33-1-15938" ref-type="table">Table III</xref> for key.</p></caption>
<alt-text>Flavonoid compounds from Carpesium cernuum L. (70&#x2013;72); see Table III for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g03.tiff"/>
</fig>
<fig id="f5-ol-33-1-15938" position="float">
<label>Figure 5.</label>
<caption><p>Other types of compounds from <italic>Carpesium cernuum</italic> L. (73&#x2013;92); see <xref rid="tIV-ol-33-1-15938" ref-type="table">Table IV</xref> for key.</p></caption>
<alt-text>Other types of compounds from Carpesium cernuum L. (73&#x2013;92); see Table IV for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g04.tiff"/>
</fig>
<fig id="f6-ol-33-1-15938" position="float">
<label>Figure 6.</label>
<caption><p>Other types of compounds from <italic>Carpesium cernuum</italic> L. (93&#x2013;109); see <xref rid="tIV-ol-33-1-15938" ref-type="table">Table IV</xref> for key.</p></caption>
<alt-text>Other types of compounds from Carpesium cernuum L. (93&#x2013;109); see Table IV for...</alt-text>
<graphic xlink:href="ol-33-01-15938-g05.tiff"/>
</fig>
<fig id="f7-ol-33-1-15938" position="float">
<label>Figure 7.</label>
<caption><p>Ineupatolide and incaspitolide A modulate the PI3K/Akt/mTOR signaling axis. p-PI3K, phosphorylated phosphatidylinositol 3-kinase; IRS, insulin receptor substrate; PIP2, phosphatidylinositol 4,5-bisphosphate; PIP3, phosphatidylinositol 3,4,5-trisphosphate; PRAS4K, proline-rich Akt substrate of 40 kDa; SQSTM1/p62, sequestosome 1; LC3-I/II/M, microtubule-associated protein light chain 3-I/II/modified; P70-S6K, 70 kDa ribosomal protein S6 kinase; CDK1/2, cyclin-dependent kinase 1/2; CCNA2, cyclin A2; p53, tumor protein p53; xIAP, X-linked inhibitor of apoptosis protein.</p></caption>
<alt-text>Ineupatolide and incaspitolide A modulate the PI3K/Akt/mTOR signaling axis. p-PI3K, phosphorylated phosphatidylinositol 3-kinase; IRS, insulin receptor substrate; PIP2,...</alt-text>
<graphic xlink:href="ol-33-01-15938-g06.tiff"/>
</fig>
<fig id="f8-ol-33-1-15938" position="float">
<label>Figure 8.</label>
<caption><p>The regulatory effect of the active component carabrone on the Hippo signaling pathway. CSNK1E, casein kinase 1 &#x03B5;; WWTR1, WW domain-containing transcription regulator 1; YAP, yes-associated protein; TAZ, transcriptional co-activator with PDZ-binding motif; TEAD, TEA domain transcription factor; MOB1, MOB kinase activator 1; ROS, reactive oxygen species.</p></caption>
<alt-text>The regulatory effect of the active component carabrone on the Hippo signaling pathway. CSNK1E, casein kinase 1 &#x03B5;; WWTR1, WW domain-containing transcription regulator 1;...</alt-text>
<graphic xlink:href="ol-33-01-15938-g07.tiff"/>
</fig>
<fig id="f9-ol-33-1-15938" position="float">
<label>Figure 9.</label>
<caption><p>Regulatory effects of the crude extract of <italic>Carpesium cernuum</italic> L. on the Wnt/&#x03B2;-catenin signaling pathway. APC, adenomatous polyposis coli; Axin, axis inhibition protein; GSK-3&#x03B2;, glycogen synthase kinase-3 beta; SFRP2, secreted frizzled-related protein 2; FZD2, frizzled class receptor 2; c-Myc, cellular myelocytomatosis oncogene; CyclinD1, cyclin D1; DKK1, dickkopf WNT signaling pathway inhibitor 1.</p></caption>
<alt-text>Regulatory effects of the crude extract of Carpesium cernuum L. on the Wnt/&#x03B2;-catenin signaling pathway. APC, adenomatous polyposis coli; Axin, axis inhibition protein;...</alt-text>
<graphic xlink:href="ol-33-01-15938-g08.tiff"/>
</fig>
<fig id="f10-ol-33-1-15938" position="float">
<label>Figure 10.</label>
<caption><p>Regulation of the MAPK signaling pathway by cernuumolide J, a bioactive constituent isolated from <italic>Carpesium cernuum</italic> L. p-p38, phosphorylated p38 mitogen-activated protein kinase; p53, tumor protein p53; NF-&#x03BA;B, nuclear factor-kappa B; ROS, reactive oxygen species; Caspase-3, cysteinyl aspartate specific proteinase-3; DNA, deoxyribonucleic acid.</p></caption>
<alt-text>Regulation of the MAPK signaling pathway by cernuumolide J, a bioactive constituent isolated from Carpesium cernuum L. p-p38, phosphorylated p38 mitogen-activated protein kinase;...</alt-text>
<graphic xlink:href="ol-33-01-15938-g09.tiff"/>
</fig>
<table-wrap id="tI-ol-33-1-15938" position="float">
<label>Table I.</label>
<caption><p>Sesquiterpenes compounds from <italic>Carpesium cernuum</italic> L.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">First author/s, year</th>
<th align="center" valign="bottom">Number</th>
<th align="center" valign="bottom">Chemical compound</th>
<th align="center" valign="bottom">Type</th>
<th align="center" valign="bottom">Molecular formula</th>
<th align="center" valign="bottom">Molecular weight</th>
<th align="center" valign="bottom">Plant part</th>
<th align="center" valign="bottom">Extract/fraction</th>
<th align="center" valign="bottom">Biological relevance (anticancer activity)</th>
<th align="center" valign="bottom">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">1</td>
<td align="left" valign="top">Cernuumolide A</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>38</sub>O<sub>10</sub></td>
<td align="center" valign="top">498</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">2</td>
<td align="left" valign="top">Cernuumolide B</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>26</sub>H<sub>40</sub>O<sub>10</sub></td>
<td align="center" valign="top">512</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">3</td>
<td align="left" valign="top">Cernuumolide C</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>26</sub>H<sub>38</sub>O<sub>10</sub></td>
<td align="center" valign="top">510</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">4</td>
<td align="left" valign="top">Cernuumolide D</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>26</sub>H<sub>40</sub>O<sub>10</sub></td>
<td align="center" valign="top">512</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">5</td>
<td align="left" valign="top">Cernuumolide E</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>19</sub>H<sub>28</sub>O<sub>8</sub></td>
<td align="center" valign="top">384</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">6</td>
<td align="left" valign="top">Cernuumolide F</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>20</sub>H<sub>28</sub>O<sub>8</sub></td>
<td align="center" valign="top">396</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">7</td>
<td align="left" valign="top">Cernuumolide G</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>20</sub>H<sub>28</sub>O<sub>8</sub></td>
<td align="center" valign="top">396</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">8</td>
<td align="left" valign="top">Cernuumolide H</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Moderate cytotoxicity toward A549, HCT116, MDA-MB-231, BEL-7404, IC<sub>50</sub> values ranging from 0.87 &#x00B5;M to 2.02 &#x00B5;M</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">9</td>
<td align="left" valign="top">Cernuumolide I</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>8</sub></td>
<td align="center" valign="top">438</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">10</td>
<td align="left" valign="top">Cernuumolide J</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>8</sub></td>
<td align="center" valign="top">450</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">11</td>
<td align="left" valign="top">(2<italic>S</italic>,4<italic>S</italic>,5<italic>R</italic>,6<italic>S</italic>, 8<italic>R</italic>,9<italic>R</italic>)-5,8-diangeloyloxy-4,9-dihydroxy-2,9-epoxyger-macran-6,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">478</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">12</td>
<td align="left" valign="top">(2<italic>R</italic>,4<italic>S</italic>,5<italic>R</italic>,6<italic>S</italic>, 8<italic>R</italic>,9<italic>S</italic>,2&#x2032;<italic>S</italic>)-8-angeloyloxy-4,9-dihydroxy-2,9-epoxy-5-(2-methylbutanoy-loxy)ger-macran-6,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>36</sub>O<sub>9</sub></td>
<td align="center" valign="top">480</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2016</td>
<td align="center" valign="top">13</td>
<td align="left" valign="top">(2<italic>R</italic>&#x002A;,4<italic>S</italic>&#x002A;,5<italic>R</italic>&#x002A;, 6<italic>S</italic>&#x002A;,8<italic>R</italic>&#x002A;,9<italic>S</italic>&#x002A;)-8-angeloyloxy-4,9-dihydroxy-2,9-epoxy-5-(2-methylpro-panoy-loxy) germacran-6,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No significant cytotoxicity against A549, HCT116, MDA-MB-231, BEL-7404 in this assay</td>
<td align="center" valign="top">(<xref rid="b9-ol-33-1-15938" ref-type="bibr">9</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2021</td>
<td align="center" valign="top">14</td>
<td align="left" valign="top">(4<italic>R</italic>&#x002A;,5<italic>R</italic>&#x002A;,6<italic>S</italic>&#x002A;, 8<italic>R</italic>&#x002A;,9<italic>R</italic>&#x002A;)-5-angeloyloxy-4,8-dihydroxy-9-(2-methylpro-panoyloxy)-3-oxogermac-ran-6,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Displayed moderate <italic>in vitro</italic> cytotoxicity against HEL, KG-1a and K562 human leukemia cell lines with reported IC<sub>50</sub> values. It could trigger apoptosis in leukemia cells. No <italic>in vivo</italic> experiments were performed, and no cytotoxic evaluation on breast cancer or other solid tumor cell lines was described in this paper.</td>
<td align="center" valign="top">(<xref rid="b58-ol-33-1-15938" ref-type="bibr">58</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Dong, 2024</td>
<td align="center" valign="top">15</td>
<td align="left" valign="top">4<italic>&#x03B2;</italic>&#x2212;8<italic>&#x03B1;</italic>-dihy-droxy-5<italic>&#x03B2;</italic>-iso-butyryloxy-9<italic>&#x03B2;</italic>&#x2212;3-methylbutyry-loxy-3-oxo-germacran-7<italic>&#x03B2;</italic>, 12<italic>&#x03B1;</italic>-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>36</sub>O<sub>9</sub></td>
<td align="center" valign="top">468</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Plant crude extract</td>
<td align="left" valign="top">Antitumor/cytotoxic activity against multiple human tumor cell lines; antibacterial activity against bacteria and phytopatho-genic fungi; anti-inflammatory activity via suppressing inflam-matory mediators and related signalling pathways; anti-HSV-1 antiviral activity; anti-plasmo-dial (antimalarial) activity against Plasmodium falciparum D10 strain.</td>
<td align="center" valign="top">(<xref rid="b10-ol-33-1-15938" ref-type="bibr">10</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2018</td>
<td align="center" valign="top">16</td>
<td align="left" valign="top">Carpescernolide A</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>16</sub>H<sub>22</sub>O<sub>6</sub></td>
<td align="center" valign="top">310</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Exhibited moderate in-<italic>vitro</italic> cytotoxic activity against SMMC-7721 human hepato-cellular carcinoma cells. No cytotoxic assessment on breast cancer, leukemia and other solid tumour cell lines; no <italic>in vivo</italic> animal experiments were performed in this paper.</td>
<td align="center" valign="top">(<xref rid="b11-ol-33-1-15938" ref-type="bibr">11</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2018</td>
<td align="center" valign="top">17</td>
<td align="left" valign="top">Carpescernolide B</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>20</sub>H<sub>26</sub>O<sub>7</sub></td>
<td align="center" valign="top">378</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">No anticancer bio assay data publicly available in published literature</td>
<td align="center" valign="top">(<xref rid="b11-ol-33-1-15938" ref-type="bibr">11</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Baruah <italic>et al</italic>, 1980</td>
<td align="center" valign="top">18</td>
<td align="left" valign="top">ineupatolide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>36</sub>O<sub>9</sub></td>
<td align="center" valign="top">480</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">Ethanol extract, chloroform-soluble fraction</td>
<td align="left" valign="top">No anticancer bio-assay was performed in this original isolation paper</td>
<td align="center" valign="top">(<xref rid="b12-ol-33-1-15938" ref-type="bibr">12</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2021</td>
<td align="center" valign="top">19</td>
<td align="left" valign="top">Carpescernolide C</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>19</sub>H<sub>26</sub>O<sub>7</sub></td>
<td align="center" valign="top">366</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Moderate cytotoxicity against human leukemia HEL, KG-1a and K562 cells, IC<sub>50</sub> ranging from 1.59&#x2013;5.47 &#x00B5;mol&#x00B7;l-&#x00B9;</td>
<td align="center" valign="top">(<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2021</td>
<td align="center" valign="top">20</td>
<td align="left" valign="top">Carpescernolide D</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>20</sub>H<sub>28</sub>O<sub>7</sub></td>
<td align="center" valign="top">380</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Moderate cytotoxicity against human leukemia HEL, KG-1a and K562 cells, IC<sub>50</sub> ranging from 1.59&#x2013;5.47 &#x00B5;mol&#x00B7;l-&#x00B9;</td>
<td align="center" valign="top">(<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2021</td>
<td align="center" valign="top">21</td>
<td align="left" valign="top">Carpescernolide E</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>8</sub></td>
<td align="center" valign="top">438</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; EtOH extract, EtOAc-soluble fraction</td>
<td align="left" valign="top">Moderate cytotoxicity against human leukemia HEL, KG-1a and K562 cells, IC<sub>50</sub> ranging from 1.59&#x2013;5.47 &#x00B5;mol&#x00B7;l-&#x00B9;</td>
<td align="center" valign="top">(<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Wu <italic>et al</italic>, 2017</td>
<td align="center" valign="top">22</td>
<td align="left" valign="top">Ineupatolide E</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>20</sub>H<sub>26</sub>O<sub>7</sub></td>
<td align="center" valign="top">378</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract, petroleum ether fraction</td>
<td align="left" valign="top">Showed moderate <italic>in vitro</italic> cytotoxicity against A431, A549, BGC-823, HL-60, HT-29 and MCF-7 human tumour cell lines, with IC<sub>50</sub> values provided.</td>
<td align="center" valign="top">(<xref rid="b14-ol-33-1-15938" ref-type="bibr">14</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">K&#x0142;eczek <italic>et al</italic>, 2021; Maruyama <italic>et al</italic>, 1990</td>
<td align="center" valign="top">23</td>
<td align="left" valign="top">Divaricin B</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">Ethanol extract, chloroform-soluble fraction</td>
<td align="left" valign="top">Exhibited <italic>in vitro</italic> cytotoxicity against DU145 and PC3 human prostate cancer cells and A375 melanoma cells. It also exerted anti-inflammatory activity by suppressing LPS-induced release of proinflammatory cytokines (IL-1&#x03B2;, IL-8, TNF-&#x03B1;, CCL2) in human neutrophils. No <italic>in vivo</italic> animal experiments were performed</td>
<td align="center" valign="top">(<xref rid="b15-ol-33-1-15938" ref-type="bibr">15</xref>,<xref rid="b59-ol-33-1-15938" ref-type="bibr">59</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cheng <italic>et al</italic>, 2013</td>
<td align="center" valign="top">24</td>
<td align="left" valign="top">4<italic>E</italic>&#x2212;9<italic>&#x03B2;</italic>-hydroxy-7<italic>&#x03B1;</italic>,10<italic>&#x03B1;</italic>H-germa-cra-4,11(13)-dien-12,6<italic>&#x03B1;</italic>-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">It exhibited moderate inhibitory activity against LPS-induced NO production in RAW 264.7 macrophages (anti-inflammatory assay)</td>
<td align="center" valign="top">(<xref rid="b16-ol-33-1-15938" ref-type="bibr">16</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhang <italic>et al</italic>, 2016</td>
<td align="center" valign="top">25</td>
<td align="left" valign="top">Incaspitolide A</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>8</sub></td>
<td align="center" valign="top">438</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract, petroleum ether fraction</td>
<td align="left" valign="top">Showed <italic>in vitro</italic> cytotoxicity against HeLa, SMMC-7721 and MCF-7 cancer cells with IC<sub>50</sub> values reported in the paper. No <italic>in vivo</italic> animal experiments were performed.</td>
<td align="center" valign="top">(<xref rid="b17-ol-33-1-15938" ref-type="bibr">17</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Mossa <italic>et al</italic>, 1997</td>
<td align="center" valign="top">26</td>
<td align="left" valign="top">4&#x03B1;,5&#x03B1;-epoxy-10&#x03B1;,14H-1-epi-inuviscolide</td>
<td align="left" valign="top">Guaianolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">CH<sub>2</sub>Cl<sub>2</sub> extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b18-ol-33-1-15938" ref-type="bibr">18</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Mossa <italic>et al</italic>, 1997</td>
<td align="center" valign="top">27</td>
<td align="left" valign="top">1-epi-inuviscolide</td>
<td align="left" valign="top">Guaianolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">dichloromethane extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b18-ol-33-1-15938" ref-type="bibr">18</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2010</td>
<td align="center" valign="top">28</td>
<td align="left" valign="top">4<italic>&#x03B2;</italic>,10<italic>&#x03B2;</italic>-dihy-droxy-1<italic>&#x03B1;</italic>H,5<italic>&#x03B1;</italic>H-guai-11 (<xref rid="b13-ol-33-1-15938" ref-type="bibr">13</xref>)-en-12,8<italic>&#x03B1;</italic>-olide</td>
<td align="left" valign="top">Guaianolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>4</sub></td>
<td align="center" valign="top">266</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b56-ol-33-1-15938" ref-type="bibr">56</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Dong, 2024</td>
<td align="center" valign="top">29</td>
<td align="left" valign="top">4<italic>&#x03B1;</italic>,10<italic>&#x03B1;</italic>-dihy-droxy-1<italic>&#x03B2;</italic>H,5<italic>&#x03B2;</italic>H-guaian-11(13)-en-12,8<italic>&#x03B1;</italic>-olide</td>
<td align="left" valign="top">Guaianolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>4</sub></td>
<td align="center" valign="top">266</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Plant crude extract</td>
<td align="left" valign="top">Antibacterial activity against bacterial strains and phytopatho-genic fungi; cytotoxic/antitumor potential against several human cancer cell lines; anti-inflam-matory activity by inhibition of inflammatory mediators and related signaling pathways.</td>
<td align="center" valign="top">(<xref rid="b10-ol-33-1-15938" ref-type="bibr">10</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Li <italic>et al</italic>, 2011</td>
<td align="center" valign="top">30</td>
<td align="left" valign="top">4<italic>&#x03B2;</italic>,10<italic>&#x03B2;</italic>-dihy-droxy-1<italic>&#x03B1;</italic>H,5<italic>&#x03B1;</italic>H, 11<italic>&#x03B1;</italic>H-guaian-12, 8<italic>&#x03B2;</italic>-olide</td>
<td align="left" valign="top">Guaianolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>24</sub>O<sub>4</sub></td>
<td align="center" valign="top">268</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">This compound showed antipro-liferative activity against MCF-7 human breast cancer cells in MTT assay. Some related sesquiterpene lactones could induce MCF-7 cell apoptosis.</td>
<td align="center" valign="top">(<xref rid="b65-ol-33-1-15938" ref-type="bibr">65</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2010</td>
<td align="center" valign="top">31</td>
<td align="left" valign="top">6<italic>&#x03B2;</italic>-hydroxy-8<italic>&#x03B1;</italic>-ethoxyeremophil-7(11)-en-12,8<italic>&#x03B2;</italic>-olide</td>
<td align="left" valign="top">Eremophilane</td>
<td align="left" valign="top">C<sub>17</sub>H<sub>26</sub>O<sub>4</sub></td>
<td align="center" valign="top">294</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract;EtOAc-soluble fraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b56-ol-33-1-15938" ref-type="bibr">56</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Aguiar <italic>et al</italic>, 2010</td>
<td align="center" valign="top">32</td>
<td align="left" valign="top">caryolane-1,9<italic>&#x03B2;</italic>-diol</td>
<td align="left" valign="top">Tricyclodode-cane</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>26</sub>O<sub>2</sub></td>
<td align="center" valign="top">238</td>
<td align="left" valign="top">Ripe fruit peel</td>
<td align="left" valign="top">Ethanol extract of ripe fruit peel</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b61-ol-33-1-15938" ref-type="bibr">61</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Perera <italic>et al</italic>, 2019</td>
<td align="center" valign="top">33</td>
<td align="left" valign="top">Confertin</td>
<td align="left" valign="top">Pseudoguaiane</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Twigs and leaves</td>
<td align="left" valign="top">Ethyl-acetate extract</td>
<td align="left" valign="top">Confertin showed phytotoxic activity inhibiting the growth of Lactuca sativa and Azolla stolonifera, and antifungal activity against plant-pathogenic fungi; no anticancer or <italic>in vivo</italic> assays were performed.</td>
<td align="center" valign="top">(<xref rid="b60-ol-33-1-15938" ref-type="bibr">60</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Mossa <italic>et al</italic>, 1997</td>
<td align="center" valign="top">34</td>
<td align="left" valign="top">8-epi-confertin</td>
<td align="left" valign="top">Pseudoguaiane</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">Dichloromethane extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b18-ol-33-1-15938" ref-type="bibr">18</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Gao <italic>et al</italic>, 2007</td>
<td align="center" valign="top">35</td>
<td align="left" valign="top">Ivalin</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Seeds</td>
<td align="left" valign="top">Chloroform extract</td>
<td align="left" valign="top">Ivalin exhibited significant in-<italic>vitro</italic> cytotoxic activity against HL-60 human leukemia cells; no in-<italic>vivo</italic> experiments were performed</td>
<td align="center" valign="top">(<xref rid="b19-ol-33-1-15938" ref-type="bibr">19</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Kulyyasov <italic>et al</italic>, 1996</td>
<td align="center" valign="top">36</td>
<td align="left" valign="top">isoalantolactone</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>2</sub></td>
<td align="center" valign="top">232</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b63-ol-33-1-15938" ref-type="bibr">63</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Liu <italic>et al</italic>, 2014</td>
<td align="center" valign="top">37</td>
<td align="left" valign="top">4(15)-&#x03B2;-epoxyiso-telekin</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>2</sub></td>
<td align="center" valign="top">232</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b64-ol-33-1-15938" ref-type="bibr">64</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Kulyyasov <italic>et al</italic>, 1996</td>
<td align="center" valign="top">38</td>
<td align="left" valign="top">Alantolactone</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>2</sub></td>
<td align="center" valign="top">232</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b63-ol-33-1-15938" ref-type="bibr">63</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhao <italic>et al</italic>, 2014</td>
<td align="center" valign="top">39</td>
<td align="left" valign="top">11(13)-dihydro alantolactone</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>2</sub></td>
<td align="center" valign="top">234</td>
<td align="left" valign="top">Roots</td>
<td align="left" valign="top">ethanol extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b62-ol-33-1-15938" ref-type="bibr">62</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2001</td>
<td align="center" valign="top">40</td>
<td align="left" valign="top">13-Hydroxy-5,7 (<xref rid="b11-ol-33-1-15938" ref-type="bibr">11</xref>)-eudesmadien-12,8-olide</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Roots</td>
<td align="left" valign="top">Mixed solvent EtOAc-MeOH-AcOH</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b20-ol-33-1-15938" ref-type="bibr">20</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">41</td>
<td align="left" valign="top">2<italic>&#x03B1;</italic>-Hydroxy-eudesman-4(15)-en-12,8<italic>&#x03B2;</italic>-olide</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">EtOAc fraction of 70&#x0025; ethanol extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b21-ol-33-1-15938" ref-type="bibr">21</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Lee <italic>et al</italic>, 2002</td>
<td align="center" valign="top">42</td>
<td align="left" valign="top">telekin</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">EtOAc-soluble fraction of 70&#x0025; ethanol extract</td>
<td align="left" valign="top">Telekin exhibited potent in-<italic>vitro</italic> cytotoxic activity against multiple tumour cell lines (L1210, A549, SK-OV-3, SK-MEL-2, XF-498, HCT-15) with ED<sub>50</sub> &#x003C;10 &#x00B5;M, comparable to cisplatin; no <italic>in vivo</italic> experiments were performed</td>
<td align="center" valign="top">(<xref rid="b50-ol-33-1-15938" ref-type="bibr">50</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Wang <italic>et al</italic>, 2009</td>
<td align="center" valign="top">43</td>
<td align="left" valign="top">11(13)-dihydro-telekin</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">EtOAc-soluble fraction of ethanol extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b22-ol-33-1-15938" ref-type="bibr">22</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">44</td>
<td align="left" valign="top">2<italic>&#x03B1;</italic>-hydroxy-5<italic>&#x03B1;</italic>H-eudesman-4(15), 11(13)-dien-8<italic>&#x03B2;</italic>, 12-olide</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b21-ol-33-1-15938" ref-type="bibr">21</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">45</td>
<td align="left" valign="top">2&#x03B1;-O-&#x03B2;-D-gluco-pyranosyl-5&#x03B1;, 11&#x03B1;H-eudesma-4 (<xref rid="b15-ol-33-1-15938" ref-type="bibr">15</xref>)-en-12,8&#x03B2;-olide</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>17</sub>H<sub>24</sub>O<sub>5</sub></td>
<td align="center" valign="top">308</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">95&#x0025; ethanol extract; n-BuOH-soluble fraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b51-ol-33-1-15938" ref-type="bibr">51</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">46</td>
<td align="left" valign="top">2<italic>&#x03B1;</italic>,5<italic>&#x03B1;</italic>-dihydroxy-11<italic>&#x03B1;</italic>H-eudesman-4(15)-en-12,8<italic>&#x03B2;</italic>-olide</td>
<td align="left" valign="top">Eudesmanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>4</sub></td>
<td align="center" valign="top">266</td>
<td align="left" valign="top">Seeds</td>
<td align="left" valign="top">95&#x0025; ethanol extract; EtOAc-soluble fraction</td>
<td align="left" valign="top">It exhibited appreciable cytotoxic activity against SMMC-7721 human hepatoma cells in this study.</td>
<td align="center" valign="top">(<xref rid="b23-ol-33-1-15938" ref-type="bibr">23</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Holub <italic>et al</italic>, 1972</td>
<td align="center" valign="top">47</td>
<td align="left" valign="top">carabrone</td>
<td align="left" valign="top">Carabranolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Petroleum ether extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b24-ol-33-1-15938" ref-type="bibr">24</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2012</td>
<td align="center" valign="top">48</td>
<td align="left" valign="top">Carabrol</td>
<td align="left" valign="top">Carabranolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">Carabrol showed moderate <italic>in vitro</italic> antifungal activity against Colletotrichum lagenarium using spore germination assay.</td>
<td align="center" valign="top">(<xref rid="b52-ol-33-1-15938" ref-type="bibr">52</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cheng, 2020</td>
<td align="center" valign="top">49</td>
<td align="left" valign="top">4H-xanthalongia</td>
<td align="left" valign="top">Xantanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td align="center" valign="top">248</td>
<td align="left" valign="top">Flower buds</td>
<td align="left" valign="top">Volatile oil obtained by super-critical CO<sub>2</sub> extraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b25-ol-33-1-15938" ref-type="bibr">25</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cheng, 2020</td>
<td align="center" valign="top">50</td>
<td align="left" valign="top">Xanthalongia</td>
<td align="left" valign="top">Xantanolide</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">Flower buds</td>
<td align="left" valign="top">Volatile oil obtained by super-critical CO<sub>2</sub> extraction</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b25-ol-33-1-15938" ref-type="bibr">25</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Chen <italic>et al</italic>, 2008</td>
<td align="center" valign="top">51</td>
<td align="left" valign="top">(3S,5<italic>R</italic>,6<italic>S</italic>,7<italic>E</italic>)-5,6-epoxy-3-hydroxy-7-mega-stigmene-9-one</td>
<td align="left" valign="top">Sesquiterpenes without lactone</td>
<td align="left" valign="top">C<sub>15</sub>H<sub>22</sub>O<sub>3</sub></td>
<td align="center" valign="top">250</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">95&#x0025; ethanol extract; purified by column chromatography.</td>
<td align="left" valign="top">This megastigmane was tested or <italic>in vitro</italic> cytotoxicity against fSGC-7901 (human gastric cancer) and HL-60 (human leukemia) cell lines.</td>
<td align="center" valign="top">(<xref rid="b26-ol-33-1-15938" ref-type="bibr">26</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">H&#x00E4;usler and Montag, 1989</td>
<td align="center" valign="top">52</td>
<td align="left" valign="top">S-(&#x002B;)-dehydrovo-mifoliol</td>
<td align="left" valign="top">Sesquiterpenes without lactone</td>
<td align="left" valign="top">C<sub>13</sub>H<sub>18</sub>O<sub>3</sub></td>
<td align="center" valign="top">222</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">Extract of honey</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b53-ol-33-1-15938" ref-type="bibr">53</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">53</td>
<td align="left" valign="top">2,9-epoxy-5,9-dihydroxy-8-angeloyloxy-11-methoxymethyl-4(15)-germacraen-6,12-lide</td>
<td align="left" valign="top">Germacraenlide</td>
<td align="left" valign="top">C<sub>22</sub>H<sub>30</sub>O<sub>7</sub></td>
<td align="center" valign="top">406</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">ethyl acetate fraction of ethanol extract</td>
<td align="left" valign="top">Assayed <italic>in vitro</italic> anti-leukemia activity against K562 and HEL human leukemia cell lines by MTT assay. This compound showed weak cytotoxic effect</td>
<td align="center" valign="top">(<xref rid="b27-ol-33-1-15938" ref-type="bibr">27</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">54</td>
<td align="left" valign="top">8&#x03B1;-angeloyloxy-4&#x03B2;-hydroxy-5&#x03B2;-(3-methylbutyry-loxy)-9-oxo-germacran-6&#x03B1;,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>38</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">Chloroform extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">55</td>
<td align="left" valign="top">9&#x03B2;-angeloyloxy-4&#x03B2;,8&#x03B1;-dihydroxy-5&#x03B2;-(3-methylbuty-ryloxy)-3-oxo-germacran-6&#x03B1;,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>38</sub>O<sub>8</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Chloroform extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">56</td>
<td align="left" valign="top">Incaspitolide D</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">454</td>
<td align="left" valign="top">Aerial parts</td>
<td align="left" valign="top">Chloroform extract</td>
<td align="left" valign="top">N/A</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Dong, 2024</td>
<td align="center" valign="top">57</td>
<td align="left" valign="top">4&#x03B2;,8&#x03B1;-dihydroxy-5<italic>&#x03B2;</italic>-isobutyryloxy-9&#x03B2;-(3-methylbuty-ryloxy)-3-oxo-germacran-7<italic>&#x03B2;</italic>,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>25</sub>H<sub>36</sub>O8</td>
<td align="center" valign="top">464</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Plant crude extract</td>
<td align="left" valign="top">Exhibited cytotoxic/antitumor effects on multiple human tumor cell lines; possessed antibacterial activity against bacteria and phytopathogenic fungi; exerted anti-inflammatory effects <italic>via</italic> suppressing inflammatory mediators and relevant signaling pathways; showed anti-HSV-1 antiviral and anti-plasmodial (antimalarial) activities.</td>
<td align="center" valign="top">(<xref rid="b10-ol-33-1-15938" ref-type="bibr">10</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhang <italic>et al</italic>, 2018</td>
<td align="center" valign="top">58</td>
<td align="left" valign="top">5&#x03B2;-angeloyloxy-4<italic>&#x03B2;</italic>,8&#x03B1;-dihydroxy-9<italic>&#x03B2;</italic>-isobutyryloxy-3-oxo-germacran-7<italic>&#x03B2;</italic>,12-olide</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>24</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">466</td>
<td align="left" valign="top">Seeds</td>
<td align="left" valign="top">N/A</td>
<td align="left" valign="top">Cytotoxic activity against HL-60 human leukemia cells; belongs to active germacranolide series 26&#x2013;34; &#x03B1;,&#x03B2;-unsaturated lactone is key pharmacophore.</td>
<td align="center" valign="top">(<xref rid="b54-ol-33-1-15938" ref-type="bibr">54</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhang <italic>et al</italic>, 2018</td>
<td align="center" valign="top">59</td>
<td align="left" valign="top">Divarolide E</td>
<td align="left" valign="top">Terpenoid lactone</td>
<td align="left" valign="top">C<sub>74</sub>H<sub>34</sub>O<sub>10</sub></td>
<td align="center" valign="top">482</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">95&#x0025; ethanol extract</td>
<td align="left" valign="top">Evaluated for in-<italic>vitro</italic> cytotoxi-city against HeLa (human cervical cancer) and HepG2 (human hepatocellular carcinoma) cell lines by MTT assay. divarolide E exhibited potent cytotoxic activity, and its activity was superior to the positive control cis-platin.</td>
<td align="center" valign="top">(<xref rid="b54-ol-33-1-15938" ref-type="bibr">54</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">60</td>
<td align="left" valign="top">Cardivin D</td>
<td align="left" valign="top">Germacranolide</td>
<td align="left" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">454</td>
<td align="left" valign="top">Whole plant</td>
<td align="left" valign="top">Ethyl acetate fraction of ethanol extract</td>
<td align="left" valign="top">Tested for <italic>in vitro</italic> anti-leukemia cytotoxicity against K562 and HEL human leukemia cell lines via MTT assay. It displayed potent activity, with IC<sub>50</sub> values of 2.27&#x00B1;0.46 &#x00B5;mol&#x00B7;l<sup>&#x2212;&#x00B9;</sup> (K562) and 1.84&#x00B1;0.14 &#x00B5;mol&#x00B7;l<sup>&#x2212;&#x00B9;</sup> (HEL).</td>
<td align="center" valign="top">(<xref rid="b27-ol-33-1-15938" ref-type="bibr">27</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tII-ol-33-1-15938" position="float">
<label>Table II.</label>
<caption><p>Diterpenoid compounds in <italic>Carpesium cernuum</italic> L.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">First author/s, year</th>
<th align="center" valign="bottom">Number</th>
<th align="center" valign="bottom">Chemical compound</th>
<th align="center" valign="bottom">Type</th>
<th align="center" valign="bottom">Molecular formula</th>
<th align="center" valign="bottom">Molecular weight</th>
<th align="center" valign="bottom">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2022</td>
<td align="center" valign="top">61</td>
<td align="left" valign="top">(5Z)-6-[(acetyloxy) methyl]-2-oxo-2,10,14-trimethylhexadeca-5,13-diene-11&#x03B1;-ol</td>
<td align="left" valign="top">Diterpenoids</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>36</sub>O<sub>4</sub></td>
<td align="center" valign="top">364</td>
<td align="center" valign="top">(<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2022</td>
<td align="center" valign="top">62</td>
<td align="left" valign="top">(2E,10E)-1,12-dihydroxy-18-acetoxy-3,7,15-trimethylhexadeca-2,10,14-triene</td>
<td align="left" valign="top">Diterpenoids</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>38</sub>O<sub>4</sub></td>
<td align="center" valign="top">366</td>
<td align="center" valign="top">(<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2022</td>
<td align="center" valign="top">63</td>
<td align="left" valign="top">(2E,6Z,10E,12R)-7-[(acetyloxy) methyl]-3,11,15-trimethylhexadeca-2,6,10,14-tetraene-1,12-diol</td>
<td align="left" valign="top">Diterpenoids</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>38</sub>O<sub>4</sub></td>
<td align="center" valign="top">366</td>
<td align="center" valign="top">(<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2022</td>
<td align="center" valign="top">64</td>
<td align="left" valign="top">(2E,6Z,11S,12R)-3,7,11,15-tetramethylhexadeca-2,6,14-triene-7-[(acetyloxy) methyl]-1,12,19-triol</td>
<td align="left" valign="top">Diterpenoids</td>
<td align="center" valign="top">C<sub>23</sub>H<sub>40</sub>O<sub>5</sub></td>
<td align="center" valign="top">396</td>
<td align="center" valign="top">(<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2022</td>
<td align="center" valign="top">65</td>
<td align="left" valign="top">Plauonotol</td>
<td align="left" valign="top">Diterpenoids</td>
<td align="center" valign="top">C<sub>20</sub>H<sub>34</sub>O<sub>2</sub></td>
<td align="center" valign="top">306</td>
<td align="center" valign="top">(<xref rid="b28-ol-33-1-15938" ref-type="bibr">28</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">66</td>
<td align="left" valign="top">(5Z)-2-oxo-2,10,14-trimethylhexadeca-5,13-diene-11&#x03B1;,18-diol</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>19</sub>H<sub>34</sub>O<sub>3</sub></td>
<td align="center" valign="top">310</td>
<td align="center" valign="top">(<xref rid="b29-ol-33-1-15938" ref-type="bibr">29</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">67</td>
<td align="left" valign="top">(2E,10E)-7-[(acetyloxy)methyl]-3,11,15-trimethylhexadeca-2,10,14-triene-1,12&#x03B1;-diol</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>38</sub>O<sub>4</sub></td>
<td align="center" valign="top">367</td>
<td align="center" valign="top">(<xref rid="b29-ol-33-1-15938" ref-type="bibr">29</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">68</td>
<td align="left" valign="top">(2E,6Z)-3,11,15-trimethylhexadeca-2,6,14-triene-1,12&#x03B1;,19-triol</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>19</sub>H<sub>34</sub>O<sub>3</sub></td>
<td align="center" valign="top">310</td>
<td align="center" valign="top">(<xref rid="b29-ol-33-1-15938" ref-type="bibr">29</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Dang <italic>et al</italic>, 2019</td>
<td align="center" valign="top">69</td>
<td align="left" valign="top">Incaspitolide D</td>
<td align="left" valign="top">Terpenoid lactone</td>
<td align="center" valign="top">C<sub>23</sub>H<sub>34</sub>O<sub>9</sub></td>
<td align="center" valign="top">455</td>
<td align="center" valign="top">(<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tIII-ol-33-1-15938" position="float">
<label>Table III.</label>
<caption><p>Flavonoid compounds in <italic>Carpesium cernuum</italic> L.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">First author/s, year</th>
<th align="center" valign="bottom">Number</th>
<th align="center" valign="bottom">Chemical compound name</th>
<th align="center" valign="bottom">Type</th>
<th align="center" valign="bottom">Molecular formula</th>
<th align="center" valign="bottom">Molecular weigh</th>
<th align="center" valign="bottom">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Batterham and Highet,1964</td>
<td align="center" valign="top">70</td>
<td align="left" valign="top">3,4&#x2032;,5,7-tetrahydroxyflavanonol</td>
<td align="left" valign="top">Flavonoids</td>
<td align="center" valign="top">C<sub>15</sub>H<sub>12</sub>O<sub>6</sub></td>
<td align="center" valign="top">288</td>
<td align="center" valign="top">(<xref rid="b30-ol-33-1-15938" ref-type="bibr">30</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Agrawal <italic>et al</italic>, 2024</td>
<td align="center" valign="top">71</td>
<td align="left" valign="top">Isoquercetin</td>
<td align="left" valign="top">Flavonoids</td>
<td align="center" valign="top">C<sub>21</sub>H<sub>20</sub>O<sub>12</sub></td>
<td align="center" valign="top">464</td>
<td align="center" valign="top">(<xref rid="b31-ol-33-1-15938" ref-type="bibr">31</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Beninger and Hosfield, 1999</td>
<td align="center" valign="top">72</td>
<td align="left" valign="top">3-&#x03B2;-D-glucopyranosyl-3,4&#x2032;,5,7-tetrahydroxyflavonol</td>
<td align="left" valign="top">Flavonoids</td>
<td align="center" valign="top">C<sub>17</sub>H<sub>12</sub>O<sub>9</sub></td>
<td align="center" valign="top">360</td>
<td align="center" valign="top">(<xref rid="b32-ol-33-1-15938" ref-type="bibr">32</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tIV-ol-33-1-15938" position="float">
<label>Table IV.</label>
<caption><p>Other types of compounds in <italic>Carpesium cernuum</italic> L.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">First author/s, year</th>
<th align="center" valign="bottom">Number</th>
<th align="center" valign="bottom">Chemical compound name</th>
<th align="center" valign="bottom">Type</th>
<th align="center" valign="bottom">Molecular formula</th>
<th align="center" valign="bottom">Molecular weight, Da</th>
<th align="center" valign="bottom">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">73</td>
<td align="left" valign="top">4-hydroxy-acetophenone</td>
<td align="left" valign="top">Aromatic</td>
<td align="center" valign="top">C<sub>8</sub>H<sub>8</sub>O<sub>2</sub></td>
<td align="center" valign="top">136</td>
<td align="center" valign="top">(<xref rid="b21-ol-33-1-15938" ref-type="bibr">21</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2002</td>
<td align="center" valign="top">74</td>
<td align="left" valign="top">2-hydro xy-4-methoxyacetophenone</td>
<td align="left" valign="top">Aromatic</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>10</sub>O<sub>3</sub></td>
<td align="center" valign="top">166</td>
<td align="center" valign="top">(<xref rid="b21-ol-33-1-15938" ref-type="bibr">21</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Dhavale <italic>et al</italic>, 1997</td>
<td align="center" valign="top">75</td>
<td align="left" valign="top">2,4-dimethoxy(acetophenone)</td>
<td align="left" valign="top">Aromatic</td>
<td align="center" valign="top">C<sub>10</sub>H<sub>12</sub>O<sub>4</sub></td>
<td align="center" valign="top">196</td>
<td align="center" valign="top">(<xref rid="b66-ol-33-1-15938" ref-type="bibr">66</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yang <italic>et al</italic>, 2001</td>
<td align="center" valign="top">76</td>
<td align="left" valign="top">3-methyl-8-acetoxy-9,10-diisobutyryloxy-p-cymene</td>
<td align="left" valign="top">Aromatic</td>
<td align="center" valign="top">C<sub>21</sub>H<sub>30</sub>O<sub>6</sub></td>
<td align="center" valign="top">378</td>
<td align="center" valign="top">(<xref rid="b33-ol-33-1-15938" ref-type="bibr">33</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Ma <italic>et al</italic>, 2008</td>
<td align="center" valign="top">77</td>
<td align="left" valign="top">eupatriol-9-O-&#x03B2;-D-apiofuranosyl-(1&#x2192;6)-&#x03B2;-D-glucopyranoside</td>
<td align="left" valign="top">Glycoside</td>
<td align="center" valign="top">C<sub>21</sub>H<sub>32</sub>O<sub>12</sub></td>
<td align="center" valign="top">499</td>
<td align="center" valign="top">(<xref rid="b34-ol-33-1-15938" ref-type="bibr">34</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2018</td>
<td align="center" valign="top">78</td>
<td align="left" valign="top">carpescernolides A</td>
<td align="left" valign="top">Glycoside</td>
<td align="center" valign="top">C<sub>26</sub>H<sub>34</sub>O<sub>12</sub></td>
<td align="center" valign="top">561</td>
<td align="center" valign="top">(<xref rid="b55-ol-33-1-15938" ref-type="bibr">55</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Yan <italic>et al</italic>, 2018</td>
<td align="center" valign="top">79</td>
<td align="left" valign="top">carpescernolides B</td>
<td align="left" valign="top">Glycoside</td>
<td align="center" valign="top">C<sub>26</sub>H<sub>34</sub>O<sub>12</sub></td>
<td align="center" valign="top">561</td>
<td align="center" valign="top">(<xref rid="b55-ol-33-1-15938" ref-type="bibr">55</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Greea <italic>et al</italic>, 1990</td>
<td align="center" valign="top">80</td>
<td align="left" valign="top">stigmast-5-en-3&#x03B2;-ol-7-one</td>
<td align="left" valign="top">Sterols</td>
<td align="center" valign="top">C<sub>29</sub>H<sub>48</sub>O<sub>2</sub></td>
<td align="center" valign="top">428</td>
<td align="center" valign="top">(<xref rid="b35-ol-33-1-15938" ref-type="bibr">35</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Feng <italic>et al</italic>, 2023</td>
<td align="center" valign="top">81</td>
<td align="left" valign="top">&#x03B2;-sitosterol</td>
<td align="left" valign="top">Sterols</td>
<td align="center" valign="top">C<sub>29</sub>H<sub>50</sub>O</td>
<td align="center" valign="top">414</td>
<td align="center" valign="top">(<xref rid="b27-ol-33-1-15938" ref-type="bibr">27</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Meagher <italic>et al</italic>, 1999</td>
<td align="center" valign="top">82</td>
<td align="left" valign="top">pinoresinol</td>
<td align="left" valign="top">Lignans</td>
<td align="center" valign="top">C<sub>20</sub>H<sub>22</sub>O<sub>6</sub></td>
<td align="center" valign="top">358</td>
<td align="center" valign="top">(<xref rid="b36-ol-33-1-15938" ref-type="bibr">36</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Lyu and Park, 2010</td>
<td align="center" valign="top">83</td>
<td align="left" valign="top">tortoside A</td>
<td align="left" valign="top">Lignans</td>
<td align="center" valign="top">C<sub>24</sub>H<sub>28</sub>O<sub>10</sub></td>
<td align="center" valign="top">476</td>
<td align="center" valign="top">(<xref rid="b37-ol-33-1-15938" ref-type="bibr">37</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Seo <italic>et al</italic>, 2018</td>
<td align="center" valign="top">84</td>
<td align="left" valign="top">Ursolic acid</td>
<td align="left" valign="top">Triterpenes</td>
<td align="center" valign="top">C<sub>30</sub>H<sub>48</sub>O<sub>3</sub></td>
<td align="center" valign="top">456</td>
<td align="center" valign="top">(<xref rid="b38-ol-33-1-15938" ref-type="bibr">38</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhou <italic>et al</italic>, 2017</td>
<td align="center" valign="top">85</td>
<td align="left" valign="top">aurantiamide acetate modified dipeptide</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>27</sub>H<sub>28</sub>N<sub>2</sub>O<sub>4</sub></td>
<td align="center" valign="top">444</td>
<td align="center" valign="top">(<xref rid="b49-ol-33-1-15938" ref-type="bibr">49</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Flourat <italic>et al</italic>, 2021</td>
<td align="center" valign="top">86</td>
<td align="left" valign="top">p-hydroxycinnamic acid</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>8</sub>O<sub>3</sub></td>
<td align="center" valign="top">164</td>
<td align="center" valign="top">(<xref rid="b40-ol-33-1-15938" ref-type="bibr">40</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Teng <italic>et al</italic>, 2005</td>
<td align="center" valign="top">87</td>
<td align="left" valign="top">Caffeic acid</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub></td>
<td align="center" valign="top">180</td>
<td align="center" valign="top">(<xref rid="b41-ol-33-1-15938" ref-type="bibr">41</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Teng <italic>et al</italic>, 2005</td>
<td align="center" valign="top">88</td>
<td align="left" valign="top">3,4-dihydroxybenzoic acid</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>7</sub>H<sub>6</sub>O<sub>4</sub></td>
<td align="center" valign="top">154</td>
<td align="center" valign="top">(<xref rid="b41-ol-33-1-15938" ref-type="bibr">41</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhou <italic>et al</italic>, 2021</td>
<td align="center" valign="top">89</td>
<td align="left" valign="top">2,4-dihydroxy-6-</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>10</sub>O<sub>4</sub></td>
<td align="center" valign="top">182</td>
<td align="center" valign="top">(<xref rid="b42-ol-33-1-15938" ref-type="bibr">42</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Teng <italic>et al</italic>, 2005</td>
<td align="center" valign="top">90</td>
<td align="left" valign="top">methoxyacetophenone citrusin C</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>12</sub>H<sub>14</sub>O<sub>4</sub></td>
<td align="center" valign="top">222</td>
<td align="center" valign="top">(<xref rid="b41-ol-33-1-15938" ref-type="bibr">41</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Healy <italic>et al</italic>, 2003</td>
<td align="center" valign="top">91</td>
<td align="left" valign="top">Indole-3-carboxylic acid</td>
<td align="left" valign="top">indole acid</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>7</sub>NO<sub>2</sub></td>
<td align="center" valign="top">161</td>
<td align="center" valign="top">(<xref rid="b43-ol-33-1-15938" ref-type="bibr">43</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cai <italic>et al</italic>, 2022</td>
<td align="center" valign="top">92</td>
<td align="left" valign="top">7-hydroxycoumarin</td>
<td align="left" valign="top">Coumarins</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>7</sub>O<sub>3</sub></td>
<td align="center" valign="top">162</td>
<td align="center" valign="top">(<xref rid="b44-ol-33-1-15938" ref-type="bibr">44</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Nghiem <italic>et al</italic>, 2017</td>
<td align="center" valign="top">93</td>
<td align="left" valign="top">succinic acid</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>4</sub>H<sub>6</sub>O<sub>4</sub></td>
<td align="center" valign="top">118</td>
<td align="center" valign="top">(<xref rid="b45-ol-33-1-15938" ref-type="bibr">45</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Mondul <italic>et al</italic>, 2014</td>
<td align="center" valign="top">94</td>
<td align="left" valign="top">1-stearoyl glycerate</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>25</sub>H<sub>50</sub>O<sub>4</sub></td>
<td align="center" valign="top">414</td>
<td align="center" valign="top">(<xref rid="b46-ol-33-1-15938" ref-type="bibr">46</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Moghaddam <italic>et al</italic>, 2010</td>
<td align="center" valign="top">95</td>
<td align="left" valign="top">loliolid</td>
<td align="left" valign="top">Compounds</td>
<td align="center" valign="top">C<sub>11</sub>H<sub>16</sub>O<sub>3</sub></td>
<td align="center" valign="top">196</td>
<td align="center" valign="top">(<xref rid="b47-ol-33-1-15938" ref-type="bibr">47</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Zhang <italic>et al</italic>, 2026</td>
<td align="center" valign="top">96</td>
<td align="left" valign="top">paeonol</td>
<td align="left" valign="top">Miscellaneous compounds</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>10</sub>O<sub>3</sub></td>
<td align="center" valign="top">166</td>
<td align="center" valign="top">(<xref rid="b48-ol-33-1-15938" ref-type="bibr">48</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">97</td>
<td align="left" valign="top">8-hydroxy-9,10-diisobutyryloxythymol</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>18</sub>H<sub>26</sub>O<sub>6</sub></td>
<td align="center" valign="top">338</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Ren <italic>et al</italic>, 2014</td>
<td align="center" valign="top">98</td>
<td align="left" valign="top">8-hydroxy-9-isobutyryloxy-10-(2-methylbutyryloxy)-thymol</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>34</sub>O<sub>7</sub></td>
<td align="center" valign="top">410</td>
<td align="center" valign="top">(<xref rid="b67-ol-33-1-15938" ref-type="bibr">67</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">99</td>
<td align="left" valign="top">8,9-dihydroxy-10-isobutyryloxythymol</td>
<td align="left" valign="top">Terpenoids</td>
<td align="center" valign="top">C<sub>14</sub>H<sub>22</sub>O<sub>5</sub></td>
<td align="center" valign="top">270</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Stojakowska <italic>et al</italic>, 2005</td>
<td align="center" valign="top">100</td>
<td align="left" valign="top">8,9-epoxy-10-isobutyryloxythymol isobutyrate</td>
<td align="left" valign="top">Phenol</td>
<td align="center" valign="top">C<sub>22</sub>H<sub>32</sub>O<sub>5</sub></td>
<td align="center" valign="top">376</td>
<td align="center" valign="top">(<xref rid="b68-ol-33-1-15938" ref-type="bibr">68</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz et al, 2025</td>
<td align="center" valign="top">101</td>
<td align="left" valign="top">5-CQA</td>
<td align="left" valign="top">Caffeoylquinic acids, CQAs</td>
<td align="center" valign="top">C<sub>33</sub>H<sub>18</sub>O<sub>15</sub></td>
<td align="center" valign="top">665</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Li et al, 2005</td>
<td align="center" valign="top">102</td>
<td align="left" valign="top">3,4-di-o-caffeoylquinic acid</td>
<td align="left" valign="top">Polyphenolic ester derivatives</td>
<td align="center" valign="top">C<sub>33</sub>H<sub>28</sub>O<sub>15</sub></td>
<td align="center" valign="top">665</td>
<td align="center" valign="top">(<xref rid="b69-ol-33-1-15938" ref-type="bibr">69</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Shen et al, 2010</td>
<td align="center" valign="top">103</td>
<td align="left" valign="top">1,5-Di-o-caffeoylquinic acid</td>
<td align="left" valign="top">Polyphenolic ester derivatives</td>
<td align="center" valign="top">C<sub>25</sub>H<sub>24</sub>O<sub>12</sub></td>
<td align="center" valign="top">516</td>
<td align="center" valign="top">(<xref rid="b70-ol-33-1-15938" ref-type="bibr">70</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Kim <italic>et al</italic>, 2005</td>
<td align="center" valign="top">104</td>
<td align="left" valign="top">3,5-di-o-caffeoylquinic acid</td>
<td align="left" valign="top">Polyphenolic ester derivatives</td>
<td align="center" valign="top">C<sub>25</sub>H<sub>24</sub>O<sub>12</sub></td>
<td align="center" valign="top">516</td>
<td align="center" valign="top">(<xref rid="b71-ol-33-1-15938" ref-type="bibr">71</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Miyamae <italic>et al</italic>, 2012</td>
<td align="center" valign="top">105</td>
<td align="left" valign="top">4,5-di-o-caffeoylquinic acid</td>
<td align="left" valign="top">Polyphenolic ester derivatives</td>
<td align="center" valign="top">C<sub>25</sub>H<sub>24</sub>O<sub>12</sub></td>
<td align="center" valign="top">516</td>
<td align="center" valign="top">(<xref rid="b72-ol-33-1-15938" ref-type="bibr">72</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Malarz <italic>et al</italic>, 2025</td>
<td align="center" valign="top">106</td>
<td align="left" valign="top">3-hydroxy-3,6-dimethyl-2,3-dihydrobenzofuran-2-yl isobutyrate</td>
<td align="left" valign="top">Benzofuran-derived ester compounds</td>
<td align="center" valign="top">C<sub>14</sub>H<sub>18</sub>O<sub>3</sub></td>
<td align="center" valign="top">234</td>
<td align="center" valign="top">(<xref rid="b39-ol-33-1-15938" ref-type="bibr">39</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Bakrim <italic>et al</italic>, 2022</td>
<td align="center" valign="top">107</td>
<td align="left" valign="top">Stigmasterol</td>
<td align="left" valign="top">Phytosterol derivatives</td>
<td align="center" valign="top">C<sub>29</sub>H<sub>48</sub>O</td>
<td align="center" valign="top">412</td>
<td align="center" valign="top">(<xref rid="b73-ol-33-1-15938" ref-type="bibr">73</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Kumar <italic>et al</italic>, 2021</td>
<td align="center" valign="top">108</td>
<td align="left" valign="top">Syringaldehyde</td>
<td align="left" valign="top">Phenolic aldehyde derivatives</td>
<td align="center" valign="top">C<sub>9</sub>H<sub>10</sub>O<sub>4</sub></td>
<td align="center" valign="top">182</td>
<td align="center" valign="top">(<xref rid="b74-ol-33-1-15938" ref-type="bibr">74</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Ribeiro <italic>et al</italic>, 2011</td>
<td align="center" valign="top">109</td>
<td align="left" valign="top">&#x03B2;-carotene</td>
<td align="left" valign="top">Sterols</td>
<td align="center" valign="top">C<sub>31</sub>H<sub>52</sub>O<sub>3</sub></td>
<td align="center" valign="top">472</td>
<td align="center" valign="top">(<xref rid="b75-ol-33-1-15938" ref-type="bibr">75</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tV-ol-33-1-15938" position="float">
<label>Table V.</label>
<caption><p>Standardized summary table of anticancer evidence.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Tested material</th>
<th align="center" valign="bottom">Cancer type</th>
<th align="center" valign="bottom">Experimental model</th>
<th align="center" valign="bottom">Concentration/dose</th>
<th align="center" valign="bottom">Main anticancer outcomes</th>
<th align="center" valign="bottom">Proposed mechanism</th>
<th align="center" valign="bottom">Evidence level</th>
<th align="center" valign="bottom">(Refs.)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Ineupatolide, incaspitolide A (purified monomers)</td>
<td align="left" valign="top">Prostate cancer</td>
<td align="left" valign="top"><italic>In vitro</italic> PC3 cell line</td>
<td align="left" valign="top">No exact single-molecule IC<sub>50</sub> reported</td>
<td align="left" valign="top">Suppresses prostate cancer cell proliferation and metastasis; induces cell cycle arrest and autophagic apoptosis</td>
<td align="left" valign="top">Inhibits PI3K-Akt-mTOR signaling axis, regulates cell cycle and apoptosis-related proteins</td>
<td align="left" valign="top">Level 2 (monomer, <italic>in vitro</italic>)</td>
<td align="center" valign="top">(<xref rid="b86-ol-33-1-15938" ref-type="bibr">86</xref>,<xref rid="b100-ol-33-1-15938" ref-type="bibr">100</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Carabrone (purified monomer)</td>
<td align="left" valign="top">Pancreatic cancer</td>
<td align="left" valign="top"><italic>In vitro</italic> SW1990 cell line</td>
<td align="left" valign="top">Dose-dependent intervention</td>
<td align="left" valign="top">Inhibits pancreatic cancer cell proliferation and colony formation; suppresses cell migration and invasion</td>
<td align="left" valign="top">Regulates Hippo signaling pathway; induces G2 cell cycle arrest, ROS accumulation and ferroptosis; downregulates MMP2/MMP9</td>
<td align="left" valign="top">Level 2 (monomer, <italic>in vitro</italic>)</td>
<td align="center" valign="top">(<xref rid="b77-ol-33-1-15938" ref-type="bibr">77</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Ethanol crude extract of <italic>Carpesium cernuum</italic> L.</td>
<td align="left" valign="top">Prostate cancer; breast cancer</td>
<td align="left" valign="top"><italic>In vitro</italic> PC3 cell line; <italic>in vitro</italic> MDA-MB-231, MCF7 cell lines</td>
<td align="left" valign="top">Concentration and time-dependent intervention; dose-dependent intervention</td>
<td align="left" valign="top">Inhibits PC3 cell proliferation, migration and invasion; induces late apoptosis; inhibits breast cancer cell proliferation and metastasis; suppresses ECM degradation</td>
<td align="left" valign="top">Upregulates bax/caspase-3, downregulates Bcl-2; inhibits &#x03B2;-catenin/MMP-7/c-Myc pathway; regulates MMP9/TIMP1 axis and CAMs pathway</td>
<td align="left" valign="top">Level 3 (crude extract, <italic>in vitro</italic>)</td>
<td align="center" valign="top">(<xref rid="b57-ol-33-1-15938" ref-type="bibr">57</xref>,<xref rid="b76-ol-33-1-15938" ref-type="bibr">76</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Cernuumolide J (purified monomer)</td>
<td align="left" valign="top">Leukemia</td>
<td align="left" valign="top"><italic>In vitro</italic> HEL cells</td>
<td align="left" valign="top">Dose-dependent intervention</td>
<td align="left" valign="top">Suppresses HEL cell proliferation; induces G2/M cell cycle arrest and apoptosis</td>
<td align="left" valign="top">Dual regulation of MAPK (ERK/JNK/p38) and JAK2/STAT3 pathways; activates ROS-mitochondria-caspase axis</td>
<td align="left" valign="top">Level 2 (monomer, <italic>in vitro</italic>)</td>
<td align="center" valign="top">(<xref rid="b81-ol-33-1-15938" ref-type="bibr">81</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
